Exact Mass: 211.10285020000003

Exact Mass Matches: 211.10285020000003

Found 500 metabolites which its exact mass value is equals to given mass value 211.10285020000003, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Milrinone

1,6-Dihydro-2-methyl-6-oxo-(3,4 inverted exclamation mark -bipyridine)-5-carbonitrile

C12H9N3O (211.07455839999997)


Milrinone is a member of the class of bipyridines that is 2-pyridone which is substituted at positions 3, 5, and 6 by cyano, pyrid-4-yl, and methyl groups, respectively. It is used (particularly intravenously, as the lactate) for the short-term management of severe heart failure. It has a role as an EC 3.1.4.17 (3,5-cyclic-nucleotide phosphodiesterase) inhibitor, a platelet aggregation inhibitor, a vasodilator agent and a cardiotonic drug. It is a pyridone, a nitrile and a member of bipyridines. Heart failure is a multifactorial condition that affects roughly 1-2\\% of the adult population. Often the result of long-term myocardial ischemia, cardiomyopathy, or other cardiac insults, heart failure results from an inability of the heart to perfuse peripheral tissues with sufficient oxygen and metabolites, resulting in complex systemic pathologies. Heart failure is underpinned by numerous physiological changes, including alteration in β-adrenergic signalling and cyclic adenosine monophosphate (cAMP) production, which affects the hearts contractile function and cardiac output. Milrinone is a second-generation bipyridine phosphodiesterase (PDE) inhibitor created through chemical modification of [amrinone]. As a PDE-III inhibitor, milrinone results in increased cAMP levels and improves cardiac function and peripheral vasodilation in acute decongested heart failure. Milrinone was originally synthesized at the Sterling Winthrop Research Institute in the 1980s. It was approved by the FDA on December 31, 1987, and was marketed under the trademark PRIMACOR® by Sanofi-Aventis US before being discontinued. Milrinone is a Phosphodiesterase 3 Inhibitor. The mechanism of action of milrinone is as a Phosphodiesterase 3 Inhibitor. Milrinone is a cardiovascular bipyridine agent and phosphodiesterase (PDE) III inhibitor, with positive inotropic and vasodilator activities. Upon administration, milrinone selectively inhibits PDE-mediated degradation of cyclic adenosine monophosphate (cAMP) in the heart and vascular muscles, thereby increasing cAMP and activates protein kinase A (PKA). This leads to phosphorylation of calcium ion channels and improve myocardium contractile force. Milrinone also causes vasodilation in arteriolar and venous vascular smooth muscle. A positive inotropic cardiotonic agent with vasodilator properties. It inhibits cAMP phosphodiesterase type 3 activity in myocardium and vascular smooth muscle. Milrinone is a derivative of amrinone and has 20-30 times the inotropic potency of amrinone. See also: Milrinone Lactate (active moiety of). Milrinone is only found in individuals that have used or taken this drug. It is a positive inotropic cardiotonic agent with vasodilator properties. Milrinone inhibits erythrocyte phosphodiesterase, resulting in an increase in erythrocyte cAMP activity. Subsequently, the erythrocyte membrane becomes more resistant to deformity. Along with erythrocyte activity, Milrinone also decreases blood viscosity by reducing plasma fibrinogen concentrations and increasing fibrinolytic activity. It also inhibits cAMP phosphodiesterase activity in myocardium and vascular smooth muscle. Milrinone is a derivative of amrinone and has 20-30 times the ionotropic potency of amrinone. [PubChem] C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CE - Phosphodiesterase inhibitors D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058987 - Phosphodiesterase 3 Inhibitors C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor D020011 - Protective Agents > D002316 - Cardiotonic Agents KEIO_ID M037; [MS2] KO009062 KEIO_ID M037

   

Methyldopa

3-(3,4-Dihydroxyphenyl)-alpha-methyl-L-a lanine

C10H13NO4 (211.0844538)


Methyl dopa appears as colorless or almost colorless crystals or white to yellowish-white fine powder. Almost tasteless. In the sesquihydrate form. pH (saturated aqueous solution) about 5.0. (NTP, 1992) Alpha-methyl-L-dopa is a derivative of L-tyrosine having a methyl group at the alpha-position and an additional hydroxy group at the 3-position on the phenyl ring. It has a role as a hapten, an antihypertensive agent, an alpha-adrenergic agonist, a peripheral nervous system drug and a sympatholytic agent. It is a L-tyrosine derivative and a non-proteinogenic L-alpha-amino acid. Methyldopa, or α-methyldopa, is a centrally acting sympatholytic agent and an antihypertensive agent. It is an analog of DOPA (3,4‐hydroxyphenylanine), and it is a prodrug, meaning that the drug requires biotransformation to an active metabolite for therapeutic effects. Methyldopa works by binding to alpha(α)-2 adrenergic receptors as an agonist, leading to the inhibition of adrenergic neuronal outflow and reduction of vasoconstrictor adrenergic signals. Methyldopa exists in two isomers D-α-methyldopa and L-α-methyldopa, which is the active form. First introduced in 1960 as an antihypertensive agent, methyldopa was considered to be useful in certain patient populations, such as pregnant women and patients with renal insufficiency. Since then, methyldopa was largely replaced by newer, better-tolerated antihypertensive agents; however, it is still used as monotherapy or in combination with [hydrochlorothiazide]. Methyldopa is also available as intravenous injection, which is used to manage hypertension when oral therapy is unfeasible and to treat hypertensive crisis. Methyldopa anhydrous is a Central alpha-2 Adrenergic Agonist. The mechanism of action of methyldopa anhydrous is as an Adrenergic alpha2-Agonist. Methyldopa (alpha-methyldopa or α-methyldopa) is a centrally active sympatholytic agent that has been used for more than 50 years for the treatment of hypertension. Methyldopa has been clearly linked to instances of acute and chronic liver injury that can be severe and even fatal. Methyldopa is a phenylalanine derivative and an aromatic amino acid decarboxylase inhibitor with antihypertensive activity. Methyldopa is a prodrug and is metabolized in the central nervous system. The antihypertensive action of methyldopa seems to be attributable to its conversion into alpha-methylnorepinephrine, which is a potent alpha-2 adrenergic agonist that binds to and stimulates potent central inhibitory alpha-2 adrenergic receptors. This results in a decrease in sympathetic outflow and decreased blood pressure. Methyldopa or alpha-methyldopa (brand names Aldomet, Apo-Methyldopa, Dopamet, Novomedopa) is a centrally-acting adrenergic antihypertensive medication. Its use is now deprecated following introduction of alternative safer classes of agents. However it continues to have a role in otherwise difficult to treat hypertension and gestational hypertension (formerly known as pregnancy-induced hypertension). Methyldopa is an aromatic-amino-acid decarboxylase inhibitor in animals and in man. Only methyldopa, the L-isomer of alpha-methyldopa, has the ability to inhibit dopa decarboxylase and to deplete animal tissues of norepinephrine. In man the antihypertensive activity appears to be due solely to the L-isomer. About twice the dose of the racemate (DL-alpha-methyldopa) is required for equal antihypertensive effect. Methyldopa has no direct effect on cardiac function and usually does not reduce glomerular filtration rate, renal blood flow, or filtration fraction. Cardiac output usually is maintained without cardiac acceleration. In some patients the heart rate is slowed. Normal or elevated plasma renin activity may decrease in the course of methyldopa therapy. Methyldopa reduces both supine and standing blood pressure. Methyldopa usually produces highly effective lowering of the supine pressure with infrequent symptomatic postural hypotension. Exercise hy... Methyldopa or alpha-methyldopa (brand names Aldomet, Apo-Methyldopa, Dopamet, Novomedopa) is a centrally-acting adrenergic antihypertensive medication. Its use is now deprecated following introduction of alternative safer classes of agents. However it continues to have a role in otherwise difficult to treat hypertension and gestational hypertension (formerly known as pregnancy-induced hypertension). Methyldopa is an aromatic-amino-acid decarboxylase inhibitor in animals and in man. Only methyldopa, the L-isomer of alpha-methyldopa, has the ability to inhibit dopa decarboxylase and to deplete animal tissues of norepinephrine. In man the antihypertensive activity appears to be due solely to the L-isomer. About twice the dose of the racemate (DL-alpha-methyldopa) is required for equal antihypertensive effect. Methyldopa has no direct effect on cardiac function and usually does not reduce glomerular filtration rate, renal blood flow, or filtration fraction. Cardiac output usually is maintained without cardiac acceleration. In some patients the heart rate is slowed. Normal or elevated plasma renin activity may decrease in the course of methyldopa therapy. Methyldopa reduces both supine and standing blood pressure. Methyldopa usually produces highly effective lowering of the supine pressure with infrequent symptomatic postural hypotension. Exercise hypotension and diurnal blood pressure variations rarely occur. Methyldopa, in its active metabolite form, is a central alpha-2 receptor agonist. Using methyldopa leads to alpha-2 receptor-negative feedback to sympathetic nervous system (SNS) (centrally and peripherally), allowing peripheral sympathetic nervous system tone to decrease. Such activity leads to a decrease in total peripheral resistance (TPR) and cardiac output. When introduced it was a mainstay of antihypertensive therapy, but its use has declined, with increased use of other safer classes of agents. One of its important present-day uses is in the management of pregnancy-induced hypertension, as it is relatively safe in pregnancy compared to other antihypertensive drugs (Wikipedia). Methyldopa or alpha-methyldopa (brand names Aldomet, Apo-Methyldopa, Dopamet, Novomedopa) is a centrally-acting adrenergic antihypertensive medication. Its use is now deprecated following introduction of alternative safer classes of agents. However it continues to have a role in otherwise difficult to treat hypertension and gestational hypertension (formerly known as pregnancy-induced hypertension).; Methyldopa is an aromatic-amino-acid decarboxylase inhibitor in animals and in man. Only methyldopa, the L-isomer of alpha-methyldopa, has the ability to inhibit dopa decarboxylase and to deplete animal tissues of norepinephrine. In man the antihypertensive activity appears to be due solely to the L-isomer. About twice the dose of the racemate (DL-alpha-methyldopa) is required for equal antihypertensive effect. Methyldopa has no direct effect on cardiac function and usually does not reduce glomerular filtration rate, renal blood flow, or filtration fraction. Cardiac output usually is maintained without cardiac acceleration. In some patients the heart rate is slowed. Normal or elevated plasma renin activity may decrease in the course of methyldopa therapy. Methyldopa reduces both supine and standing blood pressure. Methyldopa usually produces highly effective lowering of the supine pressure with infrequent symptomatic postural hypotension. Exercise hypotension and diurnal blood pressure variations rarely occur.; Methyldopa, in its active metabolite form, is a central alpha-2 receptor agonist. Using methyldopa leads to alpha-2 receptor-negative feedback to sympathetic nervous system (SNS) (centrally and peripherally), allowing peripheral sympathetic nervous system tone to decrease. Such activity leads to a decrease in total peripheral resistance (TPR) and cardiac output.; When introduced it was a mainstay of antihypertensive therapy, but its use has declined, with increased use of other safer classes of agents. One of its important present-day uses is in the management of pregnancy-induced hypertension, as it is relatively safe in pregnancy compared to other antihypertensive drugs. C - Cardiovascular system > C02 - Antihypertensives > C02A - Antiadrenergic agents, centrally acting > C02AB - Methyldopa D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist Methyldopa (L-(-)-α-Methyldopa), a potent antihyoertensive agent, is an alpha-adrenergic agonist (selective for α2-adrenergic receptors). Methyldopa is a proagent and is metabolized (α-Methylepinephrine) in the central nervous system[1][2].

   

propachlor

propachlor

C11H14ClNO (211.0763864)


D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals CONFIDENCE standard compound; EAWAG_UCHEM_ID 708 CONFIDENCE standard compound; INTERNAL_ID 3622 CONFIDENCE standard compound; INTERNAL_ID 8397

   

mescaline

1-Amino-2-(3,4,5-trimethoxyphenyl)ethane

C11H17NO3 (211.1208372)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens

   

Zalcitabine

4-Amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one

C9H13N3O3 (211.0956868)


A dideoxynucleoside compound in which the 3-hydroxyl group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of 5 to 3 phosphodiester linkages, which are needed for the elongation of DNA chains, thus resulting in the termination of viral DNA growth. The compound is a potent inhibitor of HIV replication at low concentrations, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal toxic side effect is axonal degeneration resulting in peripheral neuropathy. [PubChem] J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D009676 - Noxae > D000963 - Antimetabolites > D015224 - Dideoxynucleosides D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors KEIO_ID Z001 Zalcitabine is a potent nucleoside analogue reverse transcriptase inhibitor used in the treatment of HIV infection.

   

Isoproterenol

4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol

C11H17NO3 (211.1208372)


Isoproterenol is only found in individuals that have used or taken this drug. It is an isopropyl analog of epinephrine; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. [PubChem]The pharmacologic effects of isoproterenol are at least in part attributable to stimulation through beta-adrenergic receptors of intracellular adenyl cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic AMP. Increased cyclic AMP levels are associated with relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CB - Non-selective beta-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AB - Non-selective beta-adrenoreceptor agonists C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents

   

Orciprenaline

5-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,3-diol

C11H17NO3 (211.1208372)


Orciprenaline is only found in individuals that have used or taken this drug. It is a beta-adrenergic agonist used in the treatment of asthma and bronchospasms. [PubChem]Orciprenaline is a moderately selective beta(2)-adrenergic agonist that stimulates receptors of the smooth muscle in the lungs, uterus, and vasculature supplying skeletal muscle, with minimal or no effect on alpha-adrenergic receptors. Intracellularly, the actions of orciprenaline are mediated by cAMP, the production of which is augmented by beta stimulation. The drug is believed to work by activating adenylate cyclase, the enzyme responsible for producing the cellular mediator cAMP. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CB - Non-selective beta-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AB - Non-selective beta-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents

   

4-ACETYLAMINOBIPHENYL

(4-Biphenyl)Acetamide

C14H13NO (211.0997088)


   

Methoxamine

Glaxo wellcome brand 1 OF methoxamine hydrochloride

C11H17NO3 (211.1208372)


Methoxamine is only found in individuals that have used or taken this drug. It is an alpha-adrenergic agonist that causes prolonged peripheral vasoconstriction. It has little if any direct effect on the central nervous system. [PubChem]Methoxamine acts through peripheral vasoconstriction by acting as a pure alpha-1 adrenergic receptor agonist, consequently increasing systemic blood pressure (both systolic and diastolic). C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents KEIO_ID M169; [MS2] KO009056 KEIO_ID M169

   

Enicoflavine

3-(Aminomethylene)-alpha-ethenyltetrahydro-4-hydroxy-2-oxo-2H-pyran-4-acetaldehyde

C10H13NO4 (211.0844538)


   

Mebenil

2-METHYL-N-PHENYLBENZAMIDE

C14H13NO (211.0997088)


   

3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole

1,4-Dimethyl-5H-pyrido[4,3-b]indol-3-amine, 9ci

C13H13N3 (211.1109418)


3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole is a powerful mutacarcinogen found in cooked food D009676 - Noxae > D009153 - Mutagens

   

3-Hydroxy-5-methyl-L-tyrosine

3-Hydroxy-5-methyl-L-tyrosine

C10H13NO4 (211.0844538)


   

4-(Oxazolo[4,5-b]pyridin-2-yl)aniline

4-(Oxazolo[4,5-b]pyridin-2-yl)aniline

C12H9N3O (211.07455839999997)


   

4-(4-chlorophenyl)-4-hydroxypiperidine

HCL OF 4-(4-Chlorophenyl)-4-piperidinol

C11H14ClNO (211.0763864)


4-(4-chlorophenyl)-4-hydroxypiperidine is a metabolite of haloperidol. Haloperidol is a typical antipsychotic. It is in the butyrophenone class of antipsychotic medications and has pharmacological effects similar to the phenothiazines. Haloperidol is an older antipsychotic used in the treatment of schizophrenia and acute psychotic states and delirium. (Wikipedia)

   

Pramipexole

6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate

C10H17N3S (211.1143122)


Pramipexole is a medication indicated for treating Parkinsons disease and restless legs syndrome (RLS). It is also sometimes used off-label as a treatment for cluster headache or to counteract the problems with low libido experienced by some users of SSRI antidepressant drugs. Pramipexole has shown robust effects on pilot studies in bipolar disorder. Pramipexole is classified as a non-ergoline dopamine agonist. D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BC - Dopamine agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D020011 - Protective Agents > D000975 - Antioxidants Pramipexole is a selective and blood-brain barrier (BBB) penetrant dopamine D2-type receptor agonist, with Kis of 2.2 nM, 3.9 nM, 0.5 nM and 1.3 nM for D2-type receptor, D2, D3 and D4 receptors, respectively. Pramipexole can be used for the research of Parkinson's disease (PD) and restless legs syndrome (RLS)[1][2][3].

   

Varenicline

(1R,12S)-5,8,14-triazatetracyclo[10.3.1.0²,¹¹.0⁴,⁹]hexadeca-2,4,6,8,10-pentaene

C13H13N3 (211.1109418)


Varenicline is a prescription medication used to treat smoking addiction. This medication is the first approved nicotinic receptor partial agonist. Specifically, varenicline is a partial agonist of the alpha4/beta2 subtype of the nicotinic acetylcholine receptor. In addition it acts on alpha3/beta4 and weakly on alpha3beta2 and alpha6-containing receptors. A full agonism was displayed on alpha7-receptors. N - Nervous system > N07 - Other nervous system drugs > N07B - Drugs used in addictive disorders > N07BA - Drugs used in nicotine dependence C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist > C73579 - Nicotinic Agonist D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists S - Sensory organs > S01 - Ophthalmologicals D000077444 - Smoking Cessation Agents Varenicline (CP 526555) is an orally active partial agonist of α4β2 nicotinic acetylcholine receptor (α4β2 nAChR, IC50 = 250 nM), which is the principal mediator of nicotine dependence. Varenicline is also a partial agonist of α6β2 nAChR and a full agonist of α6β2 nAChR. Varenicline blocks the direct agonist effects of nicotine on nAChR while stimulates nAChR in a more moderate way, being widely used as an aid of smoking cessation[1][2][3][4][5].

   

3-Methoxytyrosine

2-amino-3-(4-hydroxy-3-methoxyphenyl)propanoic acid

C10H13NO4 (211.0844538)


3-Methoxytyrosine, also known as 3-O-methyldopa or vanilalanine, belongs to the class of organic compounds known as tyrosine and derivatives. Tyrosine and derivatives are compounds containing tyrosine or a derivative thereof resulting from reaction of tyrosine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. 3-Methoxytyrosine is one of the main biochemical markers for Aromatic L-amino acid decarboxylase (AADC, EC4.1.1.28) deficiency, an inborn error of metabolism that affects serotonin and dopamine biosynthesis. Chronically high levels of 3-methoxytyrosine are associated with aromatic L-amino acid decarboxylase (AADC, 28) deficiency, an inborn error of metabolism that affects serotonin and dopamine biosynthesis. 3-Methoxytyrosine is a potentially toxic compound. 3-Methoxytyrosine, with regard to humans, has been found to be associated with several diseases such as epilepsy, early-onset, vitamin b6-dependent and pyridoxamine 5-prime-phosphate oxidase deficiency; 3-methoxytyrosine has also been linked to several inborn metabolic disorders including sepiapterin reductase deficiency and aromatic l-amino acid decarboxylase deficiency. 3-Methoxytyrosine is one of the main biochemical markers for Aromatic L-amino acid decarboxylase (AADC, EC 4.1.1.28) deficiency, an inborn error of metabolism that affects serotonin and dopamine biosynthesis. Patients are usually detected in infancy due to developmental delay, hypotonia, and extrapyramidal movements. Diagnosis is based on an abnormal neurotransmitter metabolite profile in CSF and reduced AADC activity in plasma. 3-methoxytyrosine is elevated in CSF, plasma, and urine. (PMID 1357595, 1281049, 16288991) [HMDB] 3-O-Methyldopa (3-Methoxy-L-tyrosine) is a metabolite of L-DOPA which is formed by catechol-O-methyltransferase (COMT). 3-O-Methyldopa competitively inhibits the pharmacodynamics of l-DOPA and dopamine[1]. 3-O-Methyldopa (3-Methoxy-L-tyrosine) is a metabolite of L-DOPA which is formed by catechol-O-methyltransferase (COMT). 3-O-Methyldopa competitively inhibits the pharmacodynamics of l-DOPA and dopamine[1].

   

2-Methoxy-3-methyl-9H-carbazole

2-methoxy-3-methyl-9H-carbazole

C14H13NO (211.0997088)


2-Methoxy-3-methyl-9H-carbazole is found in herbs and spices. 2-Methoxy-3-methyl-9H-carbazole is an alkaloid from the seeds of Murraya koenigii (curryleaf tree). Alkaloid from the seeds of Murraya koenigii (curryleaf tree). 2-Methoxy-3-methyl-9H-carbazole is found in herbs and spices.

   

1-Hydroxylorcaserin

8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-1-ol

C11H14ClNO (211.0763864)


1-Hydroxylorcaserin is a metabolite of lorcaserin. Lorcaserin (APD-356, trade name Lorqess) is a weight-loss drug developed by Arena Pharmaceuticals. It has serotonergic properties and acts as an anorectic. On 22 December 2009 a New Drug Application (NDA) was submitted to the Food and Drug Administration (FDA) in the United States. On 16 September 2010, an FDA advisory panel voted to recommend against approval of the drug based on concerns over both safety and efficacy. (Wikipedia)

   

3-O-Methyl-a-methyldopa

(2S)-2-amino-3-(4-hydroxy-3-methoxyphenyl)propanoic acid

C10H13NO4 (211.0844538)


3-O-Methyl-a-methyldopa is a metabolite of methyldopa. Methyldopa (-α-Methyl-3,4-dihydroxyphenylalanine; Aldomet, Aldoril, Dopamet, Dopegyt, etc. ) is an alpha-adrenergic agonist (selective for α2-adrenergic receptors) psychoactive drug used as a sympatholytic or antihypertensive. Its use is now mostly deprecated following the introduction of alternative safer classes of agents. However, it continues to have a role in otherwise difficult to treat hypertension and gestational hypertension (also known as pregnancy-induced hypertension). (Wikipedia) 3-O-Methyldopa (3-Methoxy-L-tyrosine) is a metabolite of L-DOPA which is formed by catechol-O-methyltransferase (COMT). 3-O-Methyldopa competitively inhibits the pharmacodynamics of l-DOPA and dopamine[1]. 3-O-Methyldopa (3-Methoxy-L-tyrosine) is a metabolite of L-DOPA which is formed by catechol-O-methyltransferase (COMT). 3-O-Methyldopa competitively inhibits the pharmacodynamics of l-DOPA and dopamine[1].

   

5-Hydroxylorcaserin

(5R)-7-chloro-5-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-1-ol

C11H14ClNO (211.0763864)


5-Hydroxylorcaserin is a metabolite of lorcaserin. Lorcaserin (APD-356, trade name Lorqess) is a weight-loss drug developed by Arena Pharmaceuticals. It has serotonergic properties and acts as an anorectic. On 22 December 2009 a New Drug Application (NDA) was submitted to the Food and Drug Administration (FDA) in the United States. On 16 September 2010, an FDA advisory panel voted to recommend against approval of the drug based on concerns over both safety and efficacy. (Wikipedia)

   

7-Hydroxylorcaserin

(1R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-ol

C11H14ClNO (211.0763864)


7-Hydroxylorcaserin is a metabolite of lorcaserin. Lorcaserin (APD-356, trade name Lorqess) is a weight-loss drug developed by Arena Pharmaceuticals. It has serotonergic properties and acts as an anorectic. On 22 December 2009 a New Drug Application (NDA) was submitted to the Food and Drug Administration (FDA) in the United States. On 16 September 2010, an FDA advisory panel voted to recommend against approval of the drug based on concerns over both safety and efficacy. (Wikipedia)

   

N-Hydroxylorcaserin

(1R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-3-ol

C11H14ClNO (211.0763864)


N-Hydroxylorcaserin is a metabolite of lorcaserin. Lorcaserin (APD-356, trade name Lorqess) is a weight-loss drug developed by Arena Pharmaceuticals. It has serotonergic properties and acts as an anorectic. On 22 December 2009 a New Drug Application (NDA) was submitted to the Food and Drug Administration (FDA) in the United States. On 16 September 2010, an FDA advisory panel voted to recommend against approval of the drug based on concerns over both safety and efficacy. (Wikipedia)

   

N-Acetyl-1-methylhistidine

(2S)-2-acetamido-3-(1-methyl-1H-imidazol-4-yl)propanoic acid

C9H13N3O3 (211.0956868)


N-Acetyl-1-methylhistidine belongs to the class of organic compounds known as histidine and derivatives. Histidine and derivatives are compounds containing histidine or a derivative thereof resulting from a reaction of histidine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Acetyl-1-methylhistidine is an acetylated derivative of 1-methylhistidine and a very strong basic compound (based on its pKa). It has been found to be associated with chronic kidney disease: the higher the N-acetyl-1-methylhistidine levels, the lower the estimated glomerular filtration rate. This could make N-acetyl-1-methylhistidine a biomarker for chronic kidney disease (PMID: 24625756).

   

N-Acetyl-3-methylhistidine

(2S)-2-Acetamido-3-(1-methyl-1H-imidazol-5-yl)propionic acid

C9H13N3O3 (211.0956868)


N-Acetyl-3-methylhistidine, an N-acetyl-L-amino acid, belongs to the class of organic compounds known as histidine and derivatives. Histidine and derivatives are compounds containing histidine or a derivative thereof resulting from a reaction of histidine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Acetyl-3-methylhistidine is an acetylated derivative of 3-methylhistidine and a very strong basic compound (based on its pKa). N-Acetyl-3-methylhistidine has been found to be associated with prostate cancer (PMID: 28423352).

   

2-(3,4-Dimethoxyphenyl)-3-fluoroallylamine

2-(3,4-dimethoxyphenyl)-3-fluoroprop-2-en-1-amine

C11H14FNO2 (211.1008516)


   

Dexpramipexole

6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate

C10H17N3S (211.1143122)


   

3-Hydroxy-alpha-methyl-DL-tyrosine

2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid

C10H13NO4 (211.0844538)


C - Cardiovascular system > C02 - Antihypertensives > C02A - Antiadrenergic agents, centrally acting > C02AB - Methyldopa D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

   

Medemo

O-Ethyl S-(2-dimethylaminoethyl) methylphosphonothioate oxalate (1:1) salt

C7H18NO2PS (211.0795818)


   

Melevodopa

Levodopa methyl ester hydrochloride, (DL)-isomer

C10H13NO4 (211.0844538)


   

3-(1H-Imidazol-5-ylmethylene)-1,3-dihydro-2H-indol-2-one

3-[(1H-imidazol-5-yl)methylidene]-2,3-dihydro-1H-indol-2-one

C12H9N3O (211.07455839999997)


   

4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one

4-amino-1-[5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one

C9H13N3O3 (211.0956868)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D009676 - Noxae > D000963 - Antimetabolites > D015224 - Dideoxynucleosides D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors

   

p-Aminophenazone

4-amino-1,2-dihydrophenazin-1-one

C12H9N3O (211.07455839999997)


   

4-(2-Naphthyloxy)-2-butyne-1-amine

4-(naphthalen-2-yloxy)but-2-yn-1-amine

C14H13NO (211.0997088)


   

murrayafoline A

1-Methoxy-3-methyl-9H-carbazole

C14H13NO (211.0997088)


   
   

CJ 14877

Methyl 5-(1,2-dihydroxypropyl)-2-pyridinecarboxylate

C10H13NO4 (211.0844538)


   

n-salicyloyl-2-aminopropan-1,3-diol

n-salicyloyl-2-aminopropan-1,3-diol

C10H13NO4 (211.0844538)


   

n,n-diphenylguanidine

n,n-diphenylguanidine

C13H13N3 (211.1109418)


   

PP3

1-phenyl-1h-pyrazolo[3,4-d]pyrimidin-4-amine

C11H9N5 (211.0857914)


   

7-methyl-5-phenyl-[1,2,3,4]tetrazolo[1,5-a]pyrimidine

7-methyl-5-phenyl-[1,2,3,4]tetrazolo[1,5-a]pyrimidine

C11H9N5 (211.0857914)


   
   

2-(Cyclopropylcarbonyl)-3-(4-methylphenyl)acrylonitrile

2-(Cyclopropylcarbonyl)-3-(4-methylphenyl)acrylonitrile

C14H13NO (211.0997088)


   

N4-(sec-butyl)-5-nitropyrimidine-4,6-diamine

N4-(sec-butyl)-5-nitropyrimidine-4,6-diamine

C8H13N5O2 (211.10691980000001)


   

Nitrin

Nitrin

C13H13N3 (211.1109418)


http://casmi-contest.org/challenges-cat1-2.shtml; CASMI2012 LC Challenge 17

   
   

3-phenyl-3-(pyridin-2-yl)propanal

3-phenyl-3-(pyridin-2-yl)propanal

C14H13NO (211.0997088)


   

1,3-Diphenylguanidine

1,3-Diphenylguanidine

C13H13N3 (211.1109418)


CONFIDENCE standard compound; INTERNAL_ID 845; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2907; ORIGINAL_PRECURSOR_SCAN_NO 2905 CONFIDENCE standard compound; INTERNAL_ID 845; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2905; ORIGINAL_PRECURSOR_SCAN_NO 2903 CONFIDENCE standard compound; INTERNAL_ID 845; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2885; ORIGINAL_PRECURSOR_SCAN_NO 2881 CONFIDENCE standard compound; INTERNAL_ID 845; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2873; ORIGINAL_PRECURSOR_SCAN_NO 2871 CONFIDENCE standard compound; INTERNAL_ID 845; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2951; ORIGINAL_PRECURSOR_SCAN_NO 2949 CONFIDENCE standard compound; INTERNAL_ID 845; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2908; ORIGINAL_PRECURSOR_SCAN_NO 2904 CONFIDENCE standard compound; INTERNAL_ID 845; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6081; ORIGINAL_PRECURSOR_SCAN_NO 6079 CONFIDENCE standard compound; INTERNAL_ID 845; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6105; ORIGINAL_PRECURSOR_SCAN_NO 6104 CONFIDENCE standard compound; INTERNAL_ID 845; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6127; ORIGINAL_PRECURSOR_SCAN_NO 6125 CONFIDENCE standard compound; INTERNAL_ID 845; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6137; ORIGINAL_PRECURSOR_SCAN_NO 6136 CONFIDENCE standard compound; INTERNAL_ID 845; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6136; ORIGINAL_PRECURSOR_SCAN_NO 6134 CONFIDENCE standard compound; INTERNAL_ID 845; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6135; ORIGINAL_PRECURSOR_SCAN_NO 6134 CONFIDENCE standard compound; INTERNAL_ID 2487 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1007

   

methyl 2,2-dimethyl-3-[3-(hydroxyimino)-2-methyl-1-propenyl)-cyclopropanecarboxylate

methyl 2,2-dimethyl-3-[3-(hydroxyimino)-2-methyl-1-propenyl)-cyclopropanecarboxylate

C11H17NO3 (211.1208372)


   

3,4,5-Trimethoxybenzamide

3,4,5-Trimethoxybenzamide

C10H13NO4 (211.0844538)


   

7beta-Acetoxy-1-methoxymethyl-1,2-dehydro-8alpha-pyrrolizidin

7beta-Acetoxy-1-methoxymethyl-1,2-dehydro-8alpha-pyrrolizidin

C11H17NO3 (211.1208372)


   

2-amino-3-(2,4-dihydroxy-6-methylphenyl)propanoic acid

2-amino-3-(2,4-dihydroxy-6-methylphenyl)propanoic acid

C10H13NO4 (211.0844538)


   

DIETHYL 1H-PYRROLE-2,3-DICARBOXYLATE

DIETHYL 1H-PYRROLE-2,3-DICARBOXYLATE

C10H13NO4 (211.0844538)


   

3-(Hydroxymethyl)tyrosine

3-(Hydroxymethyl)tyrosine

C10H13NO4 (211.0844538)


   
   

2-benzylbenzamide

2-benzylbenzamide

C14H13NO (211.0997088)


   
   
   

N-Methyl-3-hydroxy-4,5-dimethoxyphenethylamine

N-Methyl-3-hydroxy-4,5-dimethoxyphenethylamine

C11H17NO3 (211.1208372)


   

Bryonamide B

Benzamide, 4-hydroxy-N-(2-hydroxyethyl)-3-methoxy-

C10H13NO4 (211.0844538)


   

4-methoxy-2,2-bipyridyl-6-carboxamidoxime|4-methoxy-6-cyano-2,2-bipyridyl|4-methoxy-[2,2]bipyridinyl-6-carbonitrile|Caeraloncyanonitril A|Caerulomycinonitril|caerulomycinonitrile

4-methoxy-2,2-bipyridyl-6-carboxamidoxime|4-methoxy-6-cyano-2,2-bipyridyl|4-methoxy-[2,2]bipyridinyl-6-carbonitrile|Caeraloncyanonitril A|Caerulomycinonitril|caerulomycinonitrile

C12H9N3O (211.07455839999997)


   
   

7-imino-7H,11H-pyrido[1,2-b][2,7]naphthyridin-6-one

7-imino-7H,11H-pyrido[1,2-b][2,7]naphthyridin-6-one

C12H9N3O (211.07455839999997)


   
   
   

Tetrahydrocantleyine

Tetrahydrocantleyine

C11H17NO3 (211.1208372)


   
   

N-[2,5-dihydroxy-4-(methoxymethyl)phenyl]acetamide

N-[2,5-dihydroxy-4-(methoxymethyl)phenyl]acetamide

C10H13NO4 (211.0844538)


   

2-Amino-3-ethyl-9H-pyrido(2,3-b)indole

2-Amino-3-ethyl-9H-pyrido(2,3-b)indole

C13H13N3 (211.1109418)


   

N,2-Diphenylacetamide

N,2-Diphenylacetamide

C14H13NO (211.0997088)


   

Methyl 5-(1,2-dihydroxypropyl)pyridine-2-carboxylate

Methyl 5-(1,2-dihydroxypropyl)pyridine-2-carboxylate

C10H13NO4 (211.0844538)


   

9H-Pyrido[3,4-b]indole-1-carboxamide

9H-Pyrido[3,4-b]indole-1-carboxamide

C12H9N3O (211.07455839999997)


   

methyl-(5-formyl-1H-pyrrole-2-yl)-4-hydroxybutyrate

methyl-(5-formyl-1H-pyrrole-2-yl)-4-hydroxybutyrate

C10H13NO4 (211.0844538)


   

4-Methylbenzanilide

4-Methylbenzanilide

C14H13NO (211.0997088)


   
   

5-methoxy-3-methyl-9H-carbazole

5-methoxy-3-methyl-9H-carbazole

C14H13NO (211.0997088)


   

4-amino-1-(tetrahydro-5-hydroxy-2h-pyran-2-yl)-2(1h)-pyrimidinone

4-amino-1-(tetrahydro-5-hydroxy-2h-pyran-2-yl)-2(1h)-pyrimidinone

C9H13N3O3 (211.0956868)


   

N-[2-(3,4-Dihydroxyphenyl)-2-hydroxyethyl]acetamide

N-[2-(3,4-Dihydroxyphenyl)-2-hydroxyethyl]acetamide

C10H13NO4 (211.0844538)


   

N-[(3,4,5-trimethoxyphenyl)methylidene]hydroxylamine

N-[(3,4,5-trimethoxyphenyl)methylidene]hydroxylamine

C10H13NO4 (211.0844538)


   

6-Maleimidocaproic acid

6-Maleimidocapronic acid

C10H13NO4 (211.0844538)


   

Varenicline

(1R,12S)-5,8,14-triazatetracyclo[10.3.1.0^{2,11}.0^{4,9}]hexadeca-2(11),3,5,7,9-pentaene

C13H13N3 (211.1109418)


N - Nervous system > N07 - Other nervous system drugs > N07B - Drugs used in addictive disorders > N07BA - Drugs used in nicotine dependence C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist > C73579 - Nicotinic Agonist D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists S - Sensory organs > S01 - Ophthalmologicals D000077444 - Smoking Cessation Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 3636 Varenicline (CP 526555) is an orally active partial agonist of α4β2 nicotinic acetylcholine receptor (α4β2 nAChR, IC50 = 250 nM), which is the principal mediator of nicotine dependence. Varenicline is also a partial agonist of α6β2 nAChR and a full agonist of α6β2 nAChR. Varenicline blocks the direct agonist effects of nicotine on nAChR while stimulates nAChR in a more moderate way, being widely used as an aid of smoking cessation[1][2][3][4][5].

   

1-methoxy-3-methyl-9H-carbazole

NCGC00385438-01!1-methoxy-3-methyl-9H-carbazole

C14H13NO (211.0997088)


   

NPE_212.1070_9.8

NPE_212.1070_9.8

C14H13NO (211.0997088)


CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 1109

   

2,3-Dideoxycytidine

2,3-Dideoxycytidine

C9H13N3O3 (211.0956868)


   

methoxamine

methoxamine

C11H17NO3 (211.1208372)


C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents

   

Milrinone

Milrinone

C12H9N3O (211.07455839999997)


CONFIDENCE standard compound; INTERNAL_ID 1122; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 869; ORIGINAL_PRECURSOR_SCAN_NO 865 C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CE - Phosphodiesterase inhibitors D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058987 - Phosphodiesterase 3 Inhibitors C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor D020011 - Protective Agents > D002316 - Cardiotonic Agents CONFIDENCE standard compound; INTERNAL_ID 1122; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 859; ORIGINAL_PRECURSOR_SCAN_NO 857 CONFIDENCE standard compound; INTERNAL_ID 1122; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 857; ORIGINAL_PRECURSOR_SCAN_NO 854 CONFIDENCE standard compound; INTERNAL_ID 1122; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 861; ORIGINAL_PRECURSOR_SCAN_NO 858 CONFIDENCE standard compound; INTERNAL_ID 1122; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 861; ORIGINAL_PRECURSOR_SCAN_NO 859 CONFIDENCE standard compound; INTERNAL_ID 1122; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 863; ORIGINAL_PRECURSOR_SCAN_NO 859 CONFIDENCE standard compound; INTERNAL_ID 1122; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1584; ORIGINAL_PRECURSOR_SCAN_NO 1582 CONFIDENCE standard compound; INTERNAL_ID 1122; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1580; ORIGINAL_PRECURSOR_SCAN_NO 1578 CONFIDENCE standard compound; INTERNAL_ID 1122; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1589; ORIGINAL_PRECURSOR_SCAN_NO 1588 CONFIDENCE standard compound; INTERNAL_ID 1122; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1605; ORIGINAL_PRECURSOR_SCAN_NO 1603 CONFIDENCE standard compound; INTERNAL_ID 1122; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1600; ORIGINAL_PRECURSOR_SCAN_NO 1599 CONFIDENCE standard compound; INTERNAL_ID 1122; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1581; ORIGINAL_PRECURSOR_SCAN_NO 1580

   

Pramipexole

(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine

C10H17N3S (211.1143122)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BC - Dopamine agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D020011 - Protective Agents > D000975 - Antioxidants Pramipexole is a selective and blood-brain barrier (BBB) penetrant dopamine D2-type receptor agonist, with Kis of 2.2 nM, 3.9 nM, 0.5 nM and 1.3 nM for D2-type receptor, D2, D3 and D4 receptors, respectively. Pramipexole can be used for the research of Parkinson's disease (PD) and restless legs syndrome (RLS)[1][2][3].

   
   

1-(6-Chloropyridin-2-yl)piperidin-4-amine

1-(6-Chloropyridin-2-yl)piperidin-4-amine

C10H14ClN3 (211.0876194)


   

mescaline

mescaline

C11H17NO3 (211.1208372)


A phenethylamine alkaloid that is phenethylamine substituted at positions 3, 4 and 5 by methoxy groups. D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens

   

Methyldopa

1H-INDAZOLE-3,6-DICARBOXYLICACID,6-METHYLESTER

C10H13NO4 (211.0844538)


CONFIDENCE standard compound; INTERNAL_ID 1284; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1003; ORIGINAL_PRECURSOR_SCAN_NO 1001 C - Cardiovascular system > C02 - Antihypertensives > C02A - Antiadrenergic agents, centrally acting > C02AB - Methyldopa D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist CONFIDENCE standard compound; INTERNAL_ID 1284; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1000; ORIGINAL_PRECURSOR_SCAN_NO 997 CONFIDENCE standard compound; INTERNAL_ID 1284; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 999; ORIGINAL_PRECURSOR_SCAN_NO 998 CONFIDENCE standard compound; INTERNAL_ID 1284; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 998; ORIGINAL_PRECURSOR_SCAN_NO 996 CONFIDENCE standard compound; INTERNAL_ID 1284; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1004; ORIGINAL_PRECURSOR_SCAN_NO 1001 CONFIDENCE standard compound; INTERNAL_ID 1284; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 996; ORIGINAL_PRECURSOR_SCAN_NO 994 CONFIDENCE standard compound; INTERNAL_ID 1284; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1895; ORIGINAL_PRECURSOR_SCAN_NO 1893 CONFIDENCE standard compound; INTERNAL_ID 1284; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1905; ORIGINAL_PRECURSOR_SCAN_NO 1903 CONFIDENCE standard compound; INTERNAL_ID 1284; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1906; ORIGINAL_PRECURSOR_SCAN_NO 1904 CONFIDENCE standard compound; INTERNAL_ID 1284; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1906; ORIGINAL_PRECURSOR_SCAN_NO 1903 Methyldopa (L-(-)-α-Methyldopa), a potent antihyoertensive agent, is an alpha-adrenergic agonist (selective for α2-adrenergic receptors). Methyldopa is a proagent and is metabolized (α-Methylepinephrine) in the central nervous system[1][2].

   
   

Methoxytyrosine

Methoxytyrosine

C10H13NO4 (211.0844538)


Annotation level-3

   

3-METHOXY-L-TYROSINE

3-METHOXY-L-TYROSINE

C10H13NO4 (211.0844538)


   

3-Methoxytyrosine

(DL)-3-O-Methyldopa

C10H13NO4 (211.0844538)


3-O-Methyldopa (3-Methoxy-L-tyrosine) is a metabolite of L-DOPA which is formed by catechol-O-methyltransferase (COMT). 3-O-Methyldopa competitively inhibits the pharmacodynamics of l-DOPA and dopamine[1]. 3-O-Methyldopa (3-Methoxy-L-tyrosine) is a metabolite of L-DOPA which is formed by catechol-O-methyltransferase (COMT). 3-O-Methyldopa competitively inhibits the pharmacodynamics of l-DOPA and dopamine[1].

   

4-(4-Chlorophenyl)-4-piperidinol

4-(4-chlorophenyl)-4-hydroxypiperidine

C11H14ClNO (211.0763864)


   

Vanilalanine

L-4-Hydroxy-3-methoxyphenylalanine

C10H13NO4 (211.0844538)


   

2-Hydroxyiminodibenzyl

2-Hydroxyiminodibenzyl

C14H13NO (211.0997088)


   

2-Methoxy-3-methylcarbazole

2-methoxy-3-methyl-9H-carbazole

C14H13NO (211.0997088)


   

3-O-Methyl-L-DOPA

3-O-Methyl-L-DOPA

C10H13NO4 (211.0844538)


3-O-Methyldopa (3-Methoxy-L-tyrosine) is a metabolite of L-DOPA which is formed by catechol-O-methyltransferase (COMT). 3-O-Methyldopa competitively inhibits the pharmacodynamics of l-DOPA and dopamine[1]. 3-O-Methyldopa (3-Methoxy-L-tyrosine) is a metabolite of L-DOPA which is formed by catechol-O-methyltransferase (COMT). 3-O-Methyldopa competitively inhibits the pharmacodynamics of l-DOPA and dopamine[1].

   

4-(azepan-1-ylmethyl)-1,3-thiazol-2-amine

4-(azepan-1-ylmethyl)-1,3-thiazol-2-amine

C10H17N3S (211.1143122)


   

6-phenylfuro[2,3-d]pyrimidin-4-amine

6-phenylfuro[2,3-d]pyrimidin-4-amine

C12H9N3O (211.07455839999997)


   

N-(6-Chloropyridin-2-yl)pivalamide

N-(6-Chloropyridin-2-yl)pivalamide

C11H14ClNO (211.0763864)


   

2-amino-4-methylbenzophenone

2-amino-4-methylbenzophenone

C14H13NO (211.0997088)


   

2-AMINO-4-METHYLBENZOPHENONE

2-AMINO-4-METHYLBENZOPHENONE

C14H13NO (211.0997088)


   

3-[2-(6-methylpyridin-2-yl)ethynyl]cyclohex-2-en-1-one

3-[2-(6-methylpyridin-2-yl)ethynyl]cyclohex-2-en-1-one

C14H13NO (211.0997088)


   

4-(1,2,3,6-TETRAHYDROPYRIDIN-4-YL)PHENOL HYDROCHLORIDE

4-(1,2,3,6-TETRAHYDROPYRIDIN-4-YL)PHENOL HYDROCHLORIDE

C11H14ClNO (211.0763864)


   

dioxethedrin

dioxethedrin

C11H17NO3 (211.1208372)


C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent

   

1-(4-Aminophenoxy)-3-ethoxy-2-propanol

1-(4-Aminophenoxy)-3-ethoxy-2-propanol

C11H17NO3 (211.1208372)


   

tert-butyl 4-amino-2-fluorobenzoate

tert-butyl 4-amino-2-fluorobenzoate

C11H14FNO2 (211.1008516)


   
   

5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate

5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate

C11H17NO3 (211.1208372)


   

5-METHYL-6-(4-MORPHOLINYL)-2,4(1H,3H)-PYRIMIDINEDIONE

5-METHYL-6-(4-MORPHOLINYL)-2,4(1H,3H)-PYRIMIDINEDIONE

C9H13N3O3 (211.0956868)


   

4-FLUOROANILINE, N-BOC PROTECTED

4-FLUOROANILINE, N-BOC PROTECTED

C11H14FNO2 (211.1008516)


   

3-METHYLBENZANILIDE

3-METHYLBENZANILIDE

C14H13NO (211.0997088)


   

6-HYDROXY-1,2,3,4-TETRAHYDRO-3-ISOQUINOLINECARBOXYLIC ACIDHYDRATE

6-HYDROXY-1,2,3,4-TETRAHYDRO-3-ISOQUINOLINECARBOXYLIC ACIDHYDRATE

C10H13NO4 (211.0844538)


   

tert-butyl 5-oxo-2-azabicyclo[2.2.1]heptane-2-carboxylate

tert-butyl 5-oxo-2-azabicyclo[2.2.1]heptane-2-carboxylate

C11H17NO3 (211.1208372)


   

5-(4-Morpholinylmethyl)-2-furoic acid

5-(4-Morpholinylmethyl)-2-furoic acid

C10H13NO4 (211.0844538)


   

(4-AMINO-FURAZAN-3-YL)-(4-METHYL-PIPERAZIN-1-YL)-METHANONE

(4-AMINO-FURAZAN-3-YL)-(4-METHYL-PIPERAZIN-1-YL)-METHANONE

C8H13N5O2 (211.10691980000001)


   

Methyl 4-amino-2,6-dimethoxybenzoate

Methyl 4-amino-2,6-dimethoxybenzoate

C10H13NO4 (211.0844538)


   

1-(3-Isopropylphenyl)cyclopropanamine hydrochloride (1:1)

1-(3-Isopropylphenyl)cyclopropanamine hydrochloride (1:1)

C12H18ClN (211.1127698)


   

2,2-DIMETHYL-5-(2-TETRAHYDROPYRROLYLIDENE)-1,3-DIOXANE-4,6-DIONE

2,2-DIMETHYL-5-(2-TETRAHYDROPYRROLYLIDENE)-1,3-DIOXANE-4,6-DIONE

C10H13NO4 (211.0844538)


   

(R)-Cyclopropyl(2,4-dimethylphenyl)Methanamine hydrochloride

(R)-Cyclopropyl(2,4-dimethylphenyl)Methanamine hydrochloride

C12H18ClN (211.1127698)


   

3-AMINO-3-(2-HYDROXY-3-METHOXY-PHENYL)-PROPIONIC ACID

3-AMINO-3-(2-HYDROXY-3-METHOXY-PHENYL)-PROPIONIC ACID

C10H13NO4 (211.0844538)


   

3-(1H-benzimidazol-2-yl)pyrazin-2-amine

3-(1H-benzimidazol-2-yl)pyrazin-2-amine

C11H9N5 (211.0857914)


   

2-Chloro-N-(2,4-dimethylphenyl)propanamide

2-Chloro-N-(2,4-dimethylphenyl)propanamide

C11H14ClNO (211.0763864)


   

N-[(2,3,4-trimethoxyphenyl)methylidene]hydroxylamine

N-[(2,3,4-trimethoxyphenyl)methylidene]hydroxylamine

C10H13NO4 (211.0844538)


   

n1-(4-isopropylphenyl)-2-chloroacetamide

n1-(4-isopropylphenyl)-2-chloroacetamide

C11H14ClNO (211.0763864)


   

3-Chloro-2,2-dimethyl-N-phenylpropanamide

3-Chloro-2,2-dimethyl-N-phenylpropanamide

C11H14ClNO (211.0763864)


   

2-(morpholin-4-ylmethyl)furan-3-carboxylic acid

2-(morpholin-4-ylmethyl)furan-3-carboxylic acid

C10H13NO4 (211.0844538)


   

4-(3-Chlorophenoxy)piperidine

4-(3-Chlorophenoxy)piperidine

C11H14ClNO (211.0763864)


   

2-pyridin-3-yl-1,3-benzoxazol-5-amine

2-pyridin-3-yl-1,3-benzoxazol-5-amine

C12H9N3O (211.07455839999997)


   

2-pyridin-4-yl-1,3-benzoxazol-5-amine

2-pyridin-4-yl-1,3-benzoxazol-5-amine

C12H9N3O (211.07455839999997)


   

1-PHENYLPIPERIDIN-4-ONE HYDROCHLORIDE

1-PHENYLPIPERIDIN-4-ONE HYDROCHLORIDE

C11H14ClNO (211.0763864)


   

2-(4-Chloromethyl-piperidin-1-yl)-pyrimidine

2-(4-Chloromethyl-piperidin-1-yl)-pyrimidine

C10H14ClN3 (211.0876194)


   

2-hydroxyethyl-dimethyl-(3-sulfopropyl)azanium,hydroxide

2-hydroxyethyl-dimethyl-(3-sulfopropyl)azanium,hydroxide

C7H17NO4S (211.0878242)


   

methyl 3-carboxy-1,4-dimethyl-1H-pyrrole-2-acetate

methyl 3-carboxy-1,4-dimethyl-1H-pyrrole-2-acetate

C10H13NO4 (211.0844538)


   

6,11-DIHYDRO-5H-BENZO[B]PYRIDO[2,3-E][1,4]DIAZEPIN-5-ONE

6,11-DIHYDRO-5H-BENZO[B]PYRIDO[2,3-E][1,4]DIAZEPIN-5-ONE

C12H9N3O (211.07455839999997)


   

1-phenylcyclohexan-1-amine,hydrochloride

1-phenylcyclohexan-1-amine,hydrochloride

C12H18ClN (211.1127698)


   

3-(DIFLUOROMETHYLENE)-1,1,2,2-TETRAFLUOROCYCLOPROPANE

3-(DIFLUOROMETHYLENE)-1,1,2,2-TETRAFLUOROCYCLOPROPANE

C11H17NOS (211.1030792)


   
   

3-[4-(3-Pyridinyl)phenyl]propanal

3-[4-(3-Pyridinyl)phenyl]propanal

C14H13NO (211.0997088)


   

tert-butyl 2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate

tert-butyl 2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate

C11H17NO3 (211.1208372)


   

(R)-cyclopentyl(phenyl)methanamine,hydrochloride

(R)-cyclopentyl(phenyl)methanamine,hydrochloride

C12H18ClN (211.1127698)


   

2,6-BIS-(1H-IMIDAZOL-2-YL)-PYRIDINE

2,6-BIS-(1H-IMIDAZOL-2-YL)-PYRIDINE

C11H9N5 (211.0857914)


   

3-AMINO-3-(2-HYDROXY-4-METHOXY-PHENYL)-PROPIONIC ACID

3-AMINO-3-(2-HYDROXY-4-METHOXY-PHENYL)-PROPIONIC ACID

C10H13NO4 (211.0844538)


   

Mefenorex

Mefenorex

C12H18ClN (211.1127698)


A - Alimentary tract and metabolism > A08 - Antiobesity preparations, excl. diet products > A08A - Antiobesity preparations, excl. diet products > A08AA - Centrally acting antiobesity products D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29728 - Anorexiant

   

1-(2-amino-3,4-dioxocyclobuten-1-yl)-1-(2-methylpropyl)urea

1-(2-amino-3,4-dioxocyclobuten-1-yl)-1-(2-methylpropyl)urea

C9H13N3O3 (211.0956868)


   

SR-57227

1-(6-Chloropyridin-2-yl)piperidin-4-amine

C10H14ClN3 (211.0876194)


   

4-(2,4-Difluorobenzyl)piperidine

4-(2,4-Difluorobenzyl)piperidine

C12H15F2N (211.1172494)


   

1-(4-chlorophenyl)-3-(dimethylamino)propan-1-one

1-(4-chlorophenyl)-3-(dimethylamino)propan-1-one

C11H14ClNO (211.0763864)


   

5,6-Dihydro-6-oxo-11H-pyrido[2,3-b][1,4]benzodiazepine

5,6-Dihydro-6-oxo-11H-pyrido[2,3-b][1,4]benzodiazepine

C12H9N3O (211.07455839999997)


   

9H-Purin-6-amine,N-phenyl-

9H-Purin-6-amine,N-phenyl-

C11H9N5 (211.0857914)


   

Dexpramipexole

Dexpramipexole

C10H17N3S (211.1143122)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D020011 - Protective Agents > D000975 - Antioxidants

   

AMINO-(2,3-DIMETHOXY-PHENYL)-ACETIC ACID

AMINO-(2,3-DIMETHOXY-PHENYL)-ACETIC ACID

C10H13NO4 (211.0844538)


   

N-(3-Chlorophenyl)pivalamide

N-(3-Chlorophenyl)pivalamide

C11H14ClNO (211.0763864)


   

2-Benzoxazolamine,N-2-pyridinyl-

2-Benzoxazolamine,N-2-pyridinyl-

C12H9N3O (211.07455839999997)


   

methyl (3R,4S)-4-(trifluoromethyl)piperidine-3-carboxylate

methyl (3R,4S)-4-(trifluoromethyl)piperidine-3-carboxylate

C8H12F3NO2 (211.08200879999998)


   

1-(2-(Phenylamino)phenyl)ethanone

1-(2-(Phenylamino)phenyl)ethanone

C14H13NO (211.0997088)


   

2-chloro-N-(2-phenylpropyl)acetamide

2-chloro-N-(2-phenylpropyl)acetamide

C11H14ClNO (211.0763864)


   

Benzene,1,4-diethoxy-2-nitro-

Benzene,1,4-diethoxy-2-nitro-

C10H13NO4 (211.0844538)


   

3-(Dimethylcarbamoyl)-4-fluorophenylboronic acid

3-(Dimethylcarbamoyl)-4-fluorophenylboronic acid

C9H11BFNO3 (211.0815978)


   

2-(Pyridin-4-yl)-1-(p-tolyl)ethanone

2-(Pyridin-4-yl)-1-(p-tolyl)ethanone

C14H13NO (211.0997088)


   

2-chloro-N-cyclohexylpyrimidin-4-amine

2-chloro-N-cyclohexylpyrimidin-4-amine

C10H14ClN3 (211.0876194)


   

Melevodopa

(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid methyl ester

C10H13NO4 (211.0844538)


N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BA - Dopa and dopa derivatives D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

   

Ethyl (2-amino-4-hydroxy-6-methyl-5-pyrimidinyl)acetate

Ethyl (2-amino-4-hydroxy-6-methyl-5-pyrimidinyl)acetate

C9H13N3O3 (211.0956868)


   

Acetamide,N,N-diphenyl-

Acetamide,N,N-diphenyl-

C14H13NO (211.0997088)


   

4-CHLORO-6-METHYL-2-(1-PIPERIDINYL)PYRIMIDINE

4-CHLORO-6-METHYL-2-(1-PIPERIDINYL)PYRIMIDINE

C10H14ClN3 (211.0876194)


   
   

2-Ethoxycarbonyl-3,5-dimethyl-1H-pyrrole-3-carboxylic acid

2-Ethoxycarbonyl-3,5-dimethyl-1H-pyrrole-3-carboxylic acid

C10H13NO4 (211.0844538)


   

(1,3-BENZOXAZOL-2-YLTHIO)ACETICACID

(1,3-BENZOXAZOL-2-YLTHIO)ACETICACID

C10H13NO4 (211.0844538)


   

2,3-Dimethoxy-6-(trimethylsilyl)pyridine

2,3-Dimethoxy-6-(trimethylsilyl)pyridine

C10H17NO2Si (211.10285020000003)


   

2,3-Dimethoxy-5-(trimethylsilyl)pyridine

2,3-Dimethoxy-5-(trimethylsilyl)pyridine

C10H17NO2Si (211.10285020000003)


   

1-(cyclobutanecarbonyl)piperidine-3-carboxylic acid

1-(cyclobutanecarbonyl)piperidine-3-carboxylic acid

C11H17NO3 (211.1208372)


   

tert-butyl N-(5-formyl-1H-imidazol-2-yl)carbamate

tert-butyl N-(5-formyl-1H-imidazol-2-yl)carbamate

C9H13N3O3 (211.0956868)


   

3-(4-chlorophenoxy)piperidine

3-(4-chlorophenoxy)piperidine

C11H14ClNO (211.0763864)


   

Levisoprenaline

Levisoprenaline

C11H17NO3 (211.1208372)


C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

Ethyl 2,4-dihydroxy-5,6-dimethylnicotinate

Ethyl 2,4-dihydroxy-5,6-dimethylnicotinate

C10H13NO4 (211.0844538)


   

[4-(aminomethyl)phenyl]-phenylmethanone

[4-(aminomethyl)phenyl]-phenylmethanone

C14H13NO (211.0997088)


   

5-hydroxy-2-(4-morpholinylmethyl)-4H-pyran-4-one(SALTDATA: FREE)

5-hydroxy-2-(4-morpholinylmethyl)-4H-pyran-4-one(SALTDATA: FREE)

C10H13NO4 (211.0844538)


   

2-PHENYL-6,7-DIHYDRO-1H-INDOL-4(5H)-ONE

2-PHENYL-6,7-DIHYDRO-1H-INDOL-4(5H)-ONE

C14H13NO (211.0997088)


   

N-(TERT-BUTYL)-2-CHLOROBENZAMIDE

N-(TERT-BUTYL)-2-CHLOROBENZAMIDE

C11H14ClNO (211.0763864)


   

6-Dimethylamino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxaldehyde

6-Dimethylamino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxaldehyde

C9H13N3O3 (211.0956868)


   
   

5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)ISOTHIAZOLE

5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)ISOTHIAZOLE

C9H14BNO2S (211.08382540000002)


   

4-(3-CHLORO-PHENYL)-PIPERIDIN-4-OL

4-(3-CHLORO-PHENYL)-PIPERIDIN-4-OL

C11H14ClNO (211.0763864)


   

(3-(Dimethylcarbamoyl)-5-fluorophenyl)boronic acid

(3-(Dimethylcarbamoyl)-5-fluorophenyl)boronic acid

C9H11BFNO3 (211.0815978)


   

4-(4-Chlorobenzyl)morpholine

4-(4-Chlorobenzyl)morpholine

C11H14ClNO (211.0763864)


   

1-(2-[(2-CHLORO-6-FLUOROBENZYL)THIO]ETHYL)-2-METHYL-5-PHENYL-1H-PYRROLE-3-CARBOXYLICACID

1-(2-[(2-CHLORO-6-FLUOROBENZYL)THIO]ETHYL)-2-METHYL-5-PHENYL-1H-PYRROLE-3-CARBOXYLICACID

C14H13NO (211.0997088)


   

Benzamide,2-chloro-N,N-diethyl-

Benzamide,2-chloro-N,N-diethyl-

C11H14ClNO (211.0763864)


   

(2,2-dimethyl-1,3-dioxolan-4-yl)methyl 2-cyanoprop-2-enoate

(2,2-dimethyl-1,3-dioxolan-4-yl)methyl 2-cyanoprop-2-enoate

C10H13NO4 (211.0844538)


   

5-(morpholin-4-ylmethyl)furan-3-carboxylic acid

5-(morpholin-4-ylmethyl)furan-3-carboxylic acid

C10H13NO4 (211.0844538)


   

5-FORMYL-2-(4-METHYL-1H-IMIDAZOL-1-YL)BENZONITRILE

5-FORMYL-2-(4-METHYL-1H-IMIDAZOL-1-YL)BENZONITRILE

C12H9N3O (211.07455839999997)


   

Benzamide, N-(phenylmethyl)-

Benzamide, N-(phenylmethyl)-

C14H13NO (211.0997088)


   

(S)-2-TERT-BUTOXYCARBONYLAMINO-3-(3-HYDROXY-PHENYL)-PROPIONICACID

(S)-2-TERT-BUTOXYCARBONYLAMINO-3-(3-HYDROXY-PHENYL)-PROPIONICACID

C10H13NO4 (211.0844538)


   

1-(1,2,3,4-Tetrahydroisoquinolin-6-yl)ethanone hydrochloride

1-(1,2,3,4-Tetrahydroisoquinolin-6-yl)ethanone hydrochloride

C11H14ClNO (211.0763864)


   

2,6-Diethoxypyridine-3-boronic acid

2,6-Diethoxypyridine-3-boronic acid

C9H14BNO4 (211.1015834)


   
   

2,2-[(3-Methoxyphenyl)imino]diethanol

2,2-[(3-Methoxyphenyl)imino]diethanol

C11H17NO3 (211.1208372)


   

1-(1H-IMIDAZOL-2-YL)-ETHANONEHCL

1-(1H-IMIDAZOL-2-YL)-ETHANONEHCL

C12H9N3O (211.07455839999997)


   

(S)-Cyclopropyl(2,4-dimethylphenyl)Methanamine hydrochloride

(S)-Cyclopropyl(2,4-dimethylphenyl)Methanamine hydrochloride

C12H18ClN (211.1127698)


   

1,2,3,4-TETRAHYDRO-ACRIDINE-9-CARBALDEHYDE

1,2,3,4-TETRAHYDRO-ACRIDINE-9-CARBALDEHYDE

C14H13NO (211.0997088)


   

methyl 5-amino-2,4-dimethoxybenzoate

methyl 5-amino-2,4-dimethoxybenzoate

C10H13NO4 (211.0844538)


   

2-PHENYL-PYRAZOLO[1,5-A]PYRIMIDIN-5-OL

2-PHENYL-PYRAZOLO[1,5-A]PYRIMIDIN-5-OL

C12H9N3O (211.07455839999997)


   

4-methylsulfanyl-6-pyrrolidin-1-yl-1,3,5-triazin-2-amine

4-methylsulfanyl-6-pyrrolidin-1-yl-1,3,5-triazin-2-amine

C8H13N5S (211.0891618)


   

4-(O-TOLYL)PIPERIDINE HYDROCHLORIDE

4-(O-TOLYL)PIPERIDINE HYDROCHLORIDE

C12H18ClN (211.1127698)


   

2-(4-Acetamidobenzylidene)malononitrile

2-(4-Acetamidobenzylidene)malononitrile

C12H9N3O (211.07455839999997)


   

(ar-vinylbenzyl)trimethylammonium chloride

(ar-vinylbenzyl)trimethylammonium chloride

C12H18ClN (211.1127698)


   
   

1-Cyclohexyl-5-Oxo-Pyrrolidine-3-Carboxylic Acid

1-Cyclohexyl-5-Oxo-Pyrrolidine-3-Carboxylic Acid

C11H17NO3 (211.1208372)


   

Benzeneacetamide, a-phenyl-

Benzeneacetamide, a-phenyl-

C14H13NO (211.0997088)


   

1-(3,4-DIFLUORO-PHENYL)-PIPERIDIN-4-ONE

1-(3,4-DIFLUORO-PHENYL)-PIPERIDIN-4-ONE

C11H11F2NO (211.080866)


   

3-amino-3-(4-hydroxy-3-methoxyphenyl)propanoic acid

3-amino-3-(4-hydroxy-3-methoxyphenyl)propanoic acid

C10H13NO4 (211.0844538)


   

(4-(Dimethylcarbamoyl)-2-fluorophenyl)boronic acid

(4-(Dimethylcarbamoyl)-2-fluorophenyl)boronic acid

C9H11BFNO3 (211.0815978)


   

2-Amino-4-isopropoxy-6-(methylamino)-5-nitroso-pyrimidine

2-Amino-4-isopropoxy-6-(methylamino)-5-nitroso-pyrimidine

C8H13N5O2 (211.10691980000001)


   

N-methyl-4-phenyldiazenylaniline

N-methyl-4-phenyldiazenylaniline

C13H13N3 (211.1109418)


   

Thiazole-5-boronic acid pinacol ester

Thiazole-5-boronic acid pinacol ester

C9H14BNO2S (211.08382540000002)


   

((3S,4R)-4-(4-chlorophenyl)pyrrolidin-3-yl)methanol

((3S,4R)-4-(4-chlorophenyl)pyrrolidin-3-yl)methanol

C11H14ClNO (211.0763864)


   

3-(3-CHLORO-PHENYL)-PROPIONIMIDIC ACID ETHYL ESTER

3-(3-CHLORO-PHENYL)-PROPIONIMIDIC ACID ETHYL ESTER

C11H14ClNO (211.0763864)


   

4-(Ethoxycarbonyl)-3,5-dimethyl-1H-pyrrole-2-carboxylic acid

4-(Ethoxycarbonyl)-3,5-dimethyl-1H-pyrrole-2-carboxylic acid

C10H13NO4 (211.0844538)


   

Methyl 2-amino-4,5-dimethoxybenzoate

Methyl 2-amino-4,5-dimethoxybenzoate

C10H13NO4 (211.0844538)


   

10-ethylphenoxazine

10-ethylphenoxazine

C14H13NO (211.0997088)


   

5,7-dimethyl-1,2,3,4-tetrahydronaphthalen-1-amine,hydrochloride

5,7-dimethyl-1,2,3,4-tetrahydronaphthalen-1-amine,hydrochloride

C12H18ClN (211.1127698)


   

tert-butyl 3-ethynylmorpholine-4-carboxylate

tert-butyl 3-ethynylmorpholine-4-carboxylate

C11H17NO3 (211.1208372)


   

Carbazole-9-ethanol

Carbazole-9-ethanol

C14H13NO (211.0997088)


   

2-Benzylpiperidine hydrochloride

2-Benzylpiperidine hydrochloride

C12H18ClN (211.1127698)


   

2-PYRIDIN-4-YL-1-M-TOLYL-ETHANONE

2-PYRIDIN-4-YL-1-M-TOLYL-ETHANONE

C14H13NO (211.0997088)


   

5-(diethylaminomethyl)-2-methylfuran-3-carboxylic acid

5-(diethylaminomethyl)-2-methylfuran-3-carboxylic acid

C11H17NO3 (211.1208372)


   

1-cyclopentyl-6-oxopiperidine-3-carboxylic acid

1-cyclopentyl-6-oxopiperidine-3-carboxylic acid

C11H17NO3 (211.1208372)


   

6-Chloro-N-cyclohexylpyrimidin-4-amine

6-Chloro-N-cyclohexylpyrimidin-4-amine

C10H14ClN3 (211.0876194)


   

N-{[Dimethoxy(methyl)silyl]methyl}aniline

N-{[Dimethoxy(methyl)silyl]methyl}aniline

C10H17NO2Si (211.10285020000003)


   

N-(4-ETHOXYPHENYL)HYDRAZINECARBOTHIOAMIDE

N-(4-ETHOXYPHENYL)HYDRAZINECARBOTHIOAMIDE

C9H13N3OS (211.0779288)


   

3-AMINO-3-(4-HYDROXY-2-METHOXY-PHENYL)-PROPIONIC ACID

3-AMINO-3-(4-HYDROXY-2-METHOXY-PHENYL)-PROPIONIC ACID

C10H13NO4 (211.0844538)


   

Benzamide,N-methyl-N-phenyl-

Benzamide,N-methyl-N-phenyl-

C14H13NO (211.0997088)


   

1-(2-HYDROXYETHYL)-4-METHANESULFONYLPIPERAZINE

1-(2-HYDROXYETHYL)-4-METHANESULFONYLPIPERAZINE

C11H17NO3 (211.1208372)


   

(S)-METHYL 2-AMINO-3-(TERT-BUTOXY)PROPANOATE

(S)-METHYL 2-AMINO-3-(TERT-BUTOXY)PROPANOATE

C8H18ClNO3 (211.0975148)


   

(R)-3-(3-Hydroxy-4-methoxyphenyl)-beta-alanine

(R)-3-(3-Hydroxy-4-methoxyphenyl)-beta-alanine

C10H13NO4 (211.0844538)


   

1H-Benz[e]isoindol-1-one,2-ethyl-2,3-dihydro-(9CI)

1H-Benz[e]isoindol-1-one,2-ethyl-2,3-dihydro-(9CI)

C14H13NO (211.0997088)


   

Amino(3,5-dimethoxyphenyl)acetic acid

Amino(3,5-dimethoxyphenyl)acetic acid

C10H13NO4 (211.0844538)


   

TERT-BUTYL 2-OXA-3-AZABICYCLO[2.2.2]OCT-5-ENE-3-CARBOXYLATE

TERT-BUTYL 2-OXA-3-AZABICYCLO[2.2.2]OCT-5-ENE-3-CARBOXYLATE

C11H17NO3 (211.1208372)


   

Methyl 2-amino-4,6-dimethoxybenzoate

Methyl 2-amino-4,6-dimethoxybenzoate

C10H13NO4 (211.0844538)


   

2-Chloro-N-[2-(2-methylphenyl)ethyl]acetamide

2-Chloro-N-[2-(2-methylphenyl)ethyl]acetamide

C11H14ClNO (211.0763864)


   

2-chloro-N-methyl-N-(2-phenylethyl)acetamide

2-chloro-N-methyl-N-(2-phenylethyl)acetamide

C11H14ClNO (211.0763864)


   

2-chloro-N-(1-phenylethyl)propanamide

2-chloro-N-(1-phenylethyl)propanamide

C11H14ClNO (211.0763864)


   

2-Amino-5-ethoxy-4-methoxybenzoic acid

2-Amino-5-ethoxy-4-methoxybenzoic acid

C10H13NO4 (211.0844538)


   

N-CYCLOHEXYLANILINE HYDROCHLORIDE

N-CYCLOHEXYLANILINE HYDROCHLORIDE

C12H18ClN (211.1127698)


   

1-Benzyl-4,4-difluoropiperidine

1-Benzyl-4,4-difluoropiperidine

C12H15F2N (211.1172494)


   

4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)PYRIMIDIN-2-AMINE

4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)PYRIMIDIN-2-AMINE

C11H9N5 (211.0857914)


   

oxazolo[4,5-b]pyridin-2-yl-phenylamine

oxazolo[4,5-b]pyridin-2-yl-phenylamine

C12H9N3O (211.07455839999997)


   

tert-Butyl(1R,4S)-2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate

tert-Butyl(1R,4S)-2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate

C11H17NO3 (211.1208372)


   
   

O-tert-Butyl-L-serine methylester hydrochloride

O-tert-Butyl-L-serine methylester hydrochloride

C8H18ClNO3 (211.0975148)


   
   

Benzenemethanamine, 3,4,5-trimethoxy-a-methyl-,(S)-

Benzenemethanamine, 3,4,5-trimethoxy-a-methyl-,(S)-

C11H17NO3 (211.1208372)


   

CIS-4-AMINOCYCLOHEXYL 2,2,2-TRIFLUOROACETATE

CIS-4-AMINOCYCLOHEXYL 2,2,2-TRIFLUOROACETATE

C8H12F3NO2 (211.08200879999998)


   

N-(2,3-DIMETHYLBENZYL)CYCLOPROPANAMINE HYDROCHLORIDE

N-(2,3-DIMETHYLBENZYL)CYCLOPROPANAMINE HYDROCHLORIDE

C12H18ClN (211.1127698)


   

tert-butyl (2-fluorophenyl)carbamate

tert-butyl (2-fluorophenyl)carbamate

C11H14FNO2 (211.1008516)


   

ethyl 2-dimethylamino-4-oxo-3H-pyrimidine-5-carboxylate

ethyl 2-dimethylamino-4-oxo-3H-pyrimidine-5-carboxylate

C9H13N3O3 (211.0956868)


   

ALPHA-(4-TOLYLIMINO)-P-CRESOL

ALPHA-(4-TOLYLIMINO)-P-CRESOL

C14H13NO (211.0997088)


   

2-ethyl-6-methyl-2-chloroacetanilide

2-chloro-N-(2-ethyl-6-methylphenyl)acetamide

C11H14ClNO (211.0763864)


   

2-Chloro-N-(2-isopropyl-phenyl)-acetamide

2-Chloro-N-(2-isopropyl-phenyl)-acetamide

C11H14ClNO (211.0763864)


   

(4-(ETHYLCARBAMOYL)-3-FLUOROPHENYL)BORONIC ACID

(4-(ETHYLCARBAMOYL)-3-FLUOROPHENYL)BORONIC ACID

C9H11BFNO3 (211.0815978)


   

3,3,3-trifluoro-2-(pyrrolidin-2-ylmethyl)propanoic acid

3,3,3-trifluoro-2-(pyrrolidin-2-ylmethyl)propanoic acid

C8H12F3NO2 (211.08200879999998)


   

5-(Benzyloxy)pyrimidine-2-carbonitrile

5-(Benzyloxy)pyrimidine-2-carbonitrile

C12H9N3O (211.07455839999997)


   

Phenol,2-[[(phenylmethyl)imino]methyl]-

Phenol,2-[[(phenylmethyl)imino]methyl]-

C14H13NO (211.0997088)


   

4-(3-Methoxypropoxy)-2,3-dimethylpyridine-N-oxide

4-(3-Methoxypropoxy)-2,3-dimethylpyridine-N-oxide

C11H17NO3 (211.1208372)


   
   

3-cyclohexyl-4-ethyl-1H-1,2,4-triazole-5-thione

3-cyclohexyl-4-ethyl-1H-1,2,4-triazole-5-thione

C10H17N3S (211.1143122)


   

2-CHLORO-N-(3-PHENYL-PROPYL)-ACETAMIDE

2-CHLORO-N-(3-PHENYL-PROPYL)-ACETAMIDE

C11H14ClNO (211.0763864)


   

4-METHYL-4-PHENYLPIPERIDINE HYDROCHLORIDE

4-METHYL-4-PHENYLPIPERIDINE HYDROCHLORIDE

C12H18ClN (211.1127698)


   

4-[[bis-(2-Hydroxyethyl)amino]methyl]phenol

4-[[bis-(2-Hydroxyethyl)amino]methyl]phenol

C11H17NO3 (211.1208372)


   

6-PHENYL-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE

6-PHENYL-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE

C14H13NO (211.0997088)


   

Ethyl 3-(4-amino-2-fluorophenyl)propanoate

Ethyl 3-(4-amino-2-fluorophenyl)propanoate

C11H14FNO2 (211.1008516)


   

4-[(E)-2-(4-Methoxyphenyl)vinyl]pyridine

4-[(E)-2-(4-Methoxyphenyl)vinyl]pyridine

C14H13NO (211.0997088)


   

Benzenemethanamine, 2,3,4-trimethoxy-a-methyl-,(S)-

Benzenemethanamine, 2,3,4-trimethoxy-a-methyl-,(S)-

C11H17NO3 (211.1208372)


   

ethyl 3-methoxy-1-methyl-2-oxo-1,2-dihydropyridine-4-carboxylate

ethyl 3-methoxy-1-methyl-2-oxo-1,2-dihydropyridine-4-carboxylate

C10H13NO4 (211.0844538)


   

1-Propanol,2-amino-2-methyl-,benzoate

1-Propanol,2-amino-2-methyl-,benzoate

C11H17NO3 (211.1208372)


   

1H-PYRAZOLE-5-CARBOXALDEHYDE, 3-(1,1-DIMETHYLETHYL)-1-METHYL-4-NITRO-

1H-PYRAZOLE-5-CARBOXALDEHYDE, 3-(1,1-DIMETHYLETHYL)-1-METHYL-4-NITRO-

C9H13N3O3 (211.0956868)


   

(4-(DIMETHYLCARBAMOYL)-3-FLUOROPHENYL)BORONIC ACID

(4-(DIMETHYLCARBAMOYL)-3-FLUOROPHENYL)BORONIC ACID

C9H11BFNO3 (211.0815978)


   

methyl 3-(2-amino-6-methyl-4-oxo-1H-pyrimidin-5-yl)propanoate

methyl 3-(2-amino-6-methyl-4-oxo-1H-pyrimidin-5-yl)propanoate

C9H13N3O3 (211.0956868)


   

(-)-6BETA-HYDROXYMETHYL-7ALPHA-HYDROXY-CIS-2-OXABICYCLO[3.3.0]OCTAN-3-ONE

(-)-6BETA-HYDROXYMETHYL-7ALPHA-HYDROXY-CIS-2-OXABICYCLO[3.3.0]OCTAN-3-ONE

C10H13NO4 (211.0844538)


   

diethyl 1H-pyrrole-3,4-dicarboxylate

diethyl 1H-pyrrole-3,4-dicarboxylate

C10H13NO4 (211.0844538)


   

1-amino-3-(2-methoxy-5-methylphenyl)thiourea

1-amino-3-(2-methoxy-5-methylphenyl)thiourea

C9H13N3OS (211.0779288)


   

1-(2,2-Dimethoxyethyl)-2-nitrobenzene

1-(2,2-Dimethoxyethyl)-2-nitrobenzene

C10H13NO4 (211.0844538)


   

1,2,3,9-Tetrahydro-9-Methyl-3-Methylene-4H-carbazol-4-one

1,2,3,9-Tetrahydro-9-Methyl-3-Methylene-4H-carbazol-4-one

C14H13NO (211.0997088)


   

1,2-Diphenylethanone oxime

1,2-Diphenylethanone oxime

C14H13NO (211.0997088)


   

4-(2-Aminoethoxy)-3-methoxybenzoic acid

4-(2-Aminoethoxy)-3-methoxybenzoic acid

C10H13NO4 (211.0844538)


   

1-N-Boc-3-Fluoroaniline

1-N-Boc-3-Fluoroaniline

C11H14FNO2 (211.1008516)


   

N-methyl-N-[4-oxo-4-(2,4,5,6-tetradeuteriopyridin-3-yl)butyl]nitrous amide

N-methyl-N-[4-oxo-4-(2,4,5,6-tetradeuteriopyridin-3-yl)butyl]nitrous amide

C10H9D4N3O2 (211.12588051199998)


   

Ethyl 4-Ethoxy-2-oxo-1,2-dihydropyridine-3-carboxylate

Ethyl 4-Ethoxy-2-oxo-1,2-dihydropyridine-3-carboxylate

C10H13NO4 (211.0844538)


   

Ethyl 3-oxooctahydro-1H-cyclopenta[c]pyridine-4-carboxylate

Ethyl 3-oxooctahydro-1H-cyclopenta[c]pyridine-4-carboxylate

C11H17NO3 (211.1208372)


   
   

2-(4-methylphenyl)-1-pyridin-3-ylethanone

2-(4-methylphenyl)-1-pyridin-3-ylethanone

C14H13NO (211.0997088)


   

2-Chloro-N-(2-phenylethyl)propanamide

2-Chloro-N-(2-phenylethyl)propanamide

C11H14ClNO (211.0763864)


   

2-CHLORO-N-(4-METHYLBENZYL)PROPANAMIDE

2-CHLORO-N-(4-METHYLBENZYL)PROPANAMIDE

C11H14ClNO (211.0763864)


   

Toluene, 5-ethoxy-4-methoxy-2-nitro- (6CI)

Toluene, 5-ethoxy-4-methoxy-2-nitro- (6CI)

C10H13NO4 (211.0844538)


   

Toluene, 4-ethoxy-5-methoxy-2-nitro- (6CI)

Toluene, 4-ethoxy-5-methoxy-2-nitro- (6CI)

C10H13NO4 (211.0844538)


   

Toluene, 3-ethoxy-4-methoxy-5-nitro- (6CI)

Toluene, 3-ethoxy-4-methoxy-5-nitro- (6CI)

C10H13NO4 (211.0844538)


   

Cyclobutylboronic acid MIDA ester

Cyclobutylboronic acid MIDA ester

C9H14BNO4 (211.1015834)


   

tert-butyl 6-oxo-3-aza-bicyclo[3.2.0]heptane-3-carboxylate

tert-butyl 6-oxo-3-aza-bicyclo[3.2.0]heptane-3-carboxylate

C11H17NO3 (211.1208372)


   

2-(2-methylbenzimidazol-1-yl)ethanamine,hydrochloride

2-(2-methylbenzimidazol-1-yl)ethanamine,hydrochloride

C10H14ClN3 (211.0876194)


   

N-METHYL-3,4,5-TRIMETHOXYBENZYLAMINE

N-METHYL-3,4,5-TRIMETHOXYBENZYLAMINE

C11H17NO3 (211.1208372)


   

3,4,5-TRIMETHOXYBENZALDOXIME

3,4,5-TRIMETHOXYBENZALDOXIME

C10H13NO4 (211.0844538)


   

N-(4-Methoxybenzylidene)aniline

N-(4-Methoxybenzylidene)aniline

C14H13NO (211.0997088)


   

p-((2-Chloroethyl)ethylamino)benzaldehyde

p-((2-Chloroethyl)ethylamino)benzaldehyde

C11H14ClNO (211.0763864)


   
   

3-(3-Hydroxy-4-methoxyphenyl)-DL-beta-alanine

3-(3-Hydroxy-4-methoxyphenyl)-DL-beta-alanine

C10H13NO4 (211.0844538)


   

4-(4-Methoxybenzyl)-3-thiosemicarbazide

4-(4-Methoxybenzyl)-3-thiosemicarbazide

C9H13N3OS (211.0779288)


   

2-[(Furan-2-carbonyl)-amino]-pentanoic acid

2-[(Furan-2-carbonyl)-amino]-pentanoic acid

C10H13NO4 (211.0844538)


   

MORPHOLINE,2-CHLORO-4-PHENYLMETHYL

MORPHOLINE,2-CHLORO-4-PHENYLMETHYL

C11H14ClNO (211.0763864)


   

4-CHLORO-6-ETHYL-2-(1-PYRROLIDINYL)PYRIMIDINE

4-CHLORO-6-ETHYL-2-(1-PYRROLIDINYL)PYRIMIDINE

C10H14ClN3 (211.0876194)


   
   

1-(6-chloropyridin-2-yl)-4-methylpiperazine

1-(6-chloropyridin-2-yl)-4-methylpiperazine

C10H14ClN3 (211.0876194)


   

(2R)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid

(2R)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid

C10H13NO4 (211.0844538)


   

METHYL 3-FLUORO-1-PHENYLPROPAN-2-YLCARBAMATE

METHYL 3-FLUORO-1-PHENYLPROPAN-2-YLCARBAMATE

C11H14FNO2 (211.1008516)


   

METHYL 4-CARBAMOYLBICYCLO[2.2.2]OCTANE-1-CARBOXYLATE

METHYL 4-CARBAMOYLBICYCLO[2.2.2]OCTANE-1-CARBOXYLATE

C11H17NO3 (211.1208372)


   

4-HYDROXY-6-METHYL-2-PHENYLPYRIMIDINE-5-CARBONITRILE

4-HYDROXY-6-METHYL-2-PHENYLPYRIMIDINE-5-CARBONITRILE

C12H9N3O (211.07455839999997)


   

Methyl 5-[(diethylamino)methyl]-2-furoate

Methyl 5-[(diethylamino)methyl]-2-furoate

C11H17NO3 (211.1208372)


   

2-(5-chloro-1,2,3,4-tetrahydroisoquinolin-4-yl)ethanol

2-(5-chloro-1,2,3,4-tetrahydroisoquinolin-4-yl)ethanol

C11H14ClNO (211.0763864)


   

2-(5-FORMYL-IMIDAZOL-1-YLMETHYL)-BENZONITRILE

2-(5-FORMYL-IMIDAZOL-1-YLMETHYL)-BENZONITRILE

C12H9N3O (211.07455839999997)


   

2-(7-chloro-1,2,3,4-tetrahydroisoquinolin-4-yl)ethanol

2-(7-chloro-1,2,3,4-tetrahydroisoquinolin-4-yl)ethanol

C11H14ClNO (211.0763864)


   

2-(8-chloro-1,2,3,4-tetrahydroisoquinolin-4-yl)ethanol

2-(8-chloro-1,2,3,4-tetrahydroisoquinolin-4-yl)ethanol

C11H14ClNO (211.0763864)


   

2-(Cyclopropylcarbamoyl)cyclohexanecarboxylic acid

2-(Cyclopropylcarbamoyl)cyclohexanecarboxylic acid

C11H17NO3 (211.1208372)


   

(S)-2-(3,5-DIMETHYLPHENYL)PYRROLIDINE HYDROCHLORIDE

(S)-2-(3,5-DIMETHYLPHENYL)PYRROLIDINE HYDROCHLORIDE

C12H18ClN (211.1127698)


   

Benzamide,3,4,5-trihydroxy-N-propyl- (9CI)

Benzamide,3,4,5-trihydroxy-N-propyl- (9CI)

C10H13NO4 (211.0844538)


   

2-Chloro-N-(2,4,6-trimethyl-phenyl)-acetamide

2-Chloro-N-(2,4,6-trimethyl-phenyl)-acetamide

C11H14ClNO (211.0763864)


   

4-(2-oxopyrrolidin-1-yl)cyclohexane-1-carboxylic acid

4-(2-oxopyrrolidin-1-yl)cyclohexane-1-carboxylic acid

C11H17NO3 (211.1208372)


   

6-chloro-N-cyclopentyl-2-methylpyrimidin-4-amine

6-chloro-N-cyclopentyl-2-methylpyrimidin-4-amine

C10H14ClN3 (211.0876194)


   

4-(5-FORMYL-IMIDAZOL-1-YLMETHYL)-BENZONITRILE

4-(5-FORMYL-IMIDAZOL-1-YLMETHYL)-BENZONITRILE

C12H9N3O (211.07455839999997)


   

N,N,N-trimethyl-1-(4-vinylphenyl)methanaminium chloride

N,N,N-trimethyl-1-(4-vinylphenyl)methanaminium chloride

C12H18ClN (211.1127698)


   

Triethanolamineborate

Triethanolamineborate

C6H18BNO6 (211.1227118)


   

2-(6-chloro-1,2,3,4-tetrahydroisoquinolin-4-yl)ethanol

2-(6-chloro-1,2,3,4-tetrahydroisoquinolin-4-yl)ethanol

C11H14ClNO (211.0763864)


   

Urea, 1-allyl-3-(3-ethyl-4-thiazolin-2-ylidene)- (8CI)

Urea, 1-allyl-3-(3-ethyl-4-thiazolin-2-ylidene)- (8CI)

C9H13N3OS (211.0779288)


   

HD-Ser(tBu)-OMe * HCl

HD-Ser(tBu)-OMe * HCl

C8H18ClNO3 (211.0975148)


   

1-(6-CHLORO-PYRIDAZIN-3-YL)-AZEPANE

1-(6-CHLORO-PYRIDAZIN-3-YL)-AZEPANE

C10H14ClN3 (211.0876194)


   
   

(2-AMINO-5-METHYLPHENYL)(PHENYL)METHANONE

(2-AMINO-5-METHYLPHENYL)(PHENYL)METHANONE

C14H13NO (211.0997088)


   

N-Boc-2-pyrroleboronic acid

N-Boc-2-pyrroleboronic acid

C9H14BNO4 (211.1015834)


   

3-(2-chlorophenoxy)piperidine

3-(2-chlorophenoxy)piperidine

C11H14ClNO (211.0763864)


   

3-(3-Chlorophenoxy)piperidine

3-(3-Chlorophenoxy)piperidine

C11H14ClNO (211.0763864)


   

TERT-BUTYL5-AMINO-2-FLUOROBENZOATE

TERT-BUTYL5-AMINO-2-FLUOROBENZOATE

C11H14FNO2 (211.1008516)


   
   

2-((4-fluorophenyl)ethynyl)benzeneamine

2-((4-fluorophenyl)ethynyl)benzeneamine

C14H10FN (211.07972320000002)


   

2-phenylazepane (HCl)

2-phenylazepane (HCl)

C12H18ClN (211.1127698)


   

methyl (E)-3-(5-nitrocyclohex-1-en-1-yl)acrylate

methyl (E)-3-(5-nitrocyclohex-1-en-1-yl)acrylate

C10H13NO4 (211.0844538)


   
   

2,6-Di(1-pyrazolyl)pyridine

2,6-Di(1-pyrazolyl)pyridine

C11H9N5 (211.0857914)


   

Thiazole-2-boronic acid pinacol ester

Thiazole-2-boronic acid pinacol ester

C9H14BNO2S (211.08382540000002)


   

4-(5-Fluoro-pyriMidin-2-ylaMino)-cyclohexanol

4-(5-Fluoro-pyriMidin-2-ylaMino)-cyclohexanol

C10H14FN3O (211.11208459999997)


   

(S)-1-(3-Chloro-benzyl)-pyrrolidin-3-ol

(S)-1-(3-Chloro-benzyl)-pyrrolidin-3-ol

C11H14ClNO (211.0763864)


   

(R)-1-(3-Chloro-benzyl)-pyrrolidin-3-ol

(R)-1-(3-Chloro-benzyl)-pyrrolidin-3-ol

C11H14ClNO (211.0763864)


   

(R)-N-methyl-N-phenyl tert-butane-sulfinamide

(R)-N-methyl-N-phenyl tert-butane-sulfinamide

C11H17NOS (211.1030792)


   
   

cis-7-Oxo-2-aza-bicyclo[3.2.0]heptane-2-carboxylic acid tert-butyl ester

cis-7-Oxo-2-aza-bicyclo[3.2.0]heptane-2-carboxylic acid tert-butyl ester

C11H17NO3 (211.1208372)


   

8,8-difluoro-2-azaspiro[4.5]decane hydrochloride

8,8-difluoro-2-azaspiro[4.5]decane hydrochloride

C9H16ClF2N (211.093927)


   

4-(4-fluorophenyl)sulfanylpiperidine

4-(4-fluorophenyl)sulfanylpiperidine

C11H14FNS (211.08309359999998)


   

Ethyl 4-Fluoropiperidine-4-carboxylate Hydrochloride

Ethyl 4-Fluoropiperidine-4-carboxylate Hydrochloride

C8H15ClFNO2 (211.07752920000001)


   

1H-Benzimidazol-5-amine,1-ethyl-2-methyl-(9CI)

1H-Benzimidazol-5-amine,1-ethyl-2-methyl-(9CI)

C10H14ClN3 (211.0876194)


   

tert-Butyl 6-oxo-2-azaspiro[3.3]heptane-2-carboxylate

tert-Butyl 6-oxo-2-azaspiro[3.3]heptane-2-carboxylate

C11H17NO3 (211.1208372)


   

TERT-BUTYL 5-OXO-2-AZASPIRO[3.3]HEPTANE-2-CARBOXYLATE

TERT-BUTYL 5-OXO-2-AZASPIRO[3.3]HEPTANE-2-CARBOXYLATE

C11H17NO3 (211.1208372)


   

(R)-1-(3-chloropyridin-2-yl)-3-methylpiperazine

(R)-1-(3-chloropyridin-2-yl)-3-methylpiperazine

C10H14ClN3 (211.0876194)


   

2-Ethoxy-2-(2-naphthyl)acetonitrile

2-Ethoxy-2-(2-naphthyl)acetonitrile

C14H13NO (211.0997088)


   

2-CHLORO-2,2-DIMETHYLPROPIONANILIDE

2-CHLORO-2,2-DIMETHYLPROPIONANILIDE

C11H14ClNO (211.0763864)


   

[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methanol

[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methanol

C11H17NO3 (211.1208372)


   

DIETHYLAMINE SALICYLATE

DIETHYLAMINE SALICYLATE

C11H17NO3 (211.1208372)


   

(6-(ISOBUTYLTHIO)PYRIDIN-3-YL)BORONIC ACID

(6-(ISOBUTYLTHIO)PYRIDIN-3-YL)BORONIC ACID

C9H14BNO2S (211.08382540000002)


   

2-Methyl-4-(quinolin-4-yl)but-3-yn-2-ol

2-Methyl-4-(quinolin-4-yl)but-3-yn-2-ol

C14H13NO (211.0997088)


   

Benzene,1,2-diethoxy-4-nitro-

Benzene,1,2-diethoxy-4-nitro-

C10H13NO4 (211.0844538)


   

(3-(Ethylcarbamoyl)-5-fluorophenyl)boronic acid

(3-(Ethylcarbamoyl)-5-fluorophenyl)boronic acid

C9H11BFNO3 (211.0815978)


   

6-Chloro-N-cyclohexylpyridazin-3-amine

6-Chloro-N-cyclohexylpyridazin-3-amine

C10H14ClN3 (211.0876194)


   

6-Chloro-N-cyclohexylpyrazin-2-amine

6-Chloro-N-cyclohexylpyrazin-2-amine

C10H14ClN3 (211.0876194)


   

3-(2,4-DIMETHYL-5-CARBOXY-1H-PYRROLE-3-YL)PROPANOIC ACID

3-(2,4-DIMETHYL-5-CARBOXY-1H-PYRROLE-3-YL)PROPANOIC ACID

C10H13NO4 (211.0844538)


   

2-(4-Methylpiperazino)-1,3-thiazole-5-carbaldehyde

2-(4-Methylpiperazino)-1,3-thiazole-5-carbaldehyde

C9H13N3OS (211.0779288)


   

Lisadimate

2,3-dihydroxypropyl 4-aminobenzoate

C10H13NO4 (211.0844538)


C1892 - Chemopreventive Agent > C851 - Sunscreen

   

3-AMINO-6-(MORPHOLIN-4-YL)PYRIDAZINE

3-AMINO-6-(MORPHOLIN-4-YL)PYRIDAZINE

C10H13NO4 (211.0844538)


   

4-METHYL-2-PROPOXYANILINE HYDROCHLORIDE

4-METHYL-2-PROPOXYANILINE HYDROCHLORIDE

C12H18ClN (211.1127698)


   

3-(3-METHYLPHENYL) PIPERIDINE HYDROCHLORIDE

3-(3-METHYLPHENYL) PIPERIDINE HYDROCHLORIDE

C12H18ClN (211.1127698)


   

4-(3-METHYLPHENYL) PIPERIDINE HYDROCHLORIDE

4-(3-METHYLPHENYL) PIPERIDINE HYDROCHLORIDE

C12H18ClN (211.1127698)


   

4-(4-methylphenyl)piperidine,hydrochloride

4-(4-methylphenyl)piperidine,hydrochloride

C12H18ClN (211.1127698)


   

2-(3,4-Difluorophenyl)azepane

2-(3,4-Difluorophenyl)azepane

C12H15F2N (211.1172494)


   

DL-BETA-(3,4-DIMETHOXYPHENYL)ALANINOL

DL-BETA-(3,4-DIMETHOXYPHENYL)ALANINOL

C11H17NO3 (211.1208372)


   

3-Chloro-2-(4-methylpiperazin-1-yl)pyridine

3-Chloro-2-(4-methylpiperazin-1-yl)pyridine

C10H14ClN3 (211.0876194)


   

1H-Benz[f]isoindol-1-one,2-ethyl-2,3-dihydro-(9CI)

1H-Benz[f]isoindol-1-one,2-ethyl-2,3-dihydro-(9CI)

C14H13NO (211.0997088)


   

Ethyl 2-oxo-4-(2H5)phenylbutanoate

Ethyl 2-oxo-4-(2H5)phenylbutanoate

C12H9D5O3 (211.12567529)


   

N-(tert-Butyl)-4-chlorobenzamide

N-(tert-Butyl)-4-chlorobenzamide

C11H14ClNO (211.0763864)


   

1-(3-chloro-2-pyridyl)homopiperazine

1-(3-chloro-2-pyridyl)homopiperazine

C10H14ClN3 (211.0876194)


   

Deoxybenzoin Oxime

Deoxybenzoin Oxime

C14H13NO (211.0997088)


   

(+)-4-FLUOROTARTRANILICACID

(+)-4-FLUOROTARTRANILICACID

C10H13NO4 (211.0844538)


   

4-Chloro-N-(3-methylphenyl)butanamide

4-Chloro-N-(3-methylphenyl)butanamide

C11H14ClNO (211.0763864)


   

1-(3-(Phenylamino)phenyl)ethanone

1-(3-(Phenylamino)phenyl)ethanone

C14H13NO (211.0997088)


   

4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)THIAZOLE

4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)THIAZOLE

C9H14BNO2S (211.08382540000002)


   

1-(2-chloropyridin-4-yl)-4-methylpiperazine

1-(2-chloropyridin-4-yl)-4-methylpiperazine

C10H14ClN3 (211.0876194)


   

3-(4-CHLORO-PHENYL)-PROPIONIMIDIC ACID ETHYL ESTER

3-(4-CHLORO-PHENYL)-PROPIONIMIDIC ACID ETHYL ESTER

C11H14ClNO (211.0763864)


   

2-Methyl-4-(quinolin-2-yl)but-3-yn-2-ol

2-Methyl-4-(quinolin-2-yl)but-3-yn-2-ol

C14H13NO (211.0997088)


   

AMINO-(4-HYDROXY-3-ETHOXY-PHENYL)-ACETIC ACID

AMINO-(4-HYDROXY-3-ETHOXY-PHENYL)-ACETIC ACID

C10H13NO4 (211.0844538)


   

4-(4-chlorophenoxy)piperidine

4-(4-chlorophenoxy)piperidine

C11H14ClNO (211.0763864)


   
   

L-Threonine tert-butyl ester hydrochloride

L-Threonine tert-butyl ester hydrochloride

C8H18ClNO3 (211.0975148)


   

2-AMINO-6-METHYL-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID AMIDE

2-AMINO-6-METHYL-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID AMIDE

C9H13N3OS (211.0779288)


   

1-(3-(TRIFLUOROMETHYL)PHENETHYL)HYDRAZINE

1-(3-(TRIFLUOROMETHYL)PHENETHYL)HYDRAZINE

C11H17NO3 (211.1208372)


   

(5-(Ethylcarbamoyl)-2-fluorophenyl)boronic acid

(5-(Ethylcarbamoyl)-2-fluorophenyl)boronic acid

C9H11BFNO3 (211.0815978)


   

(3-(Ethylcarbamoyl)-4-fluorophenyl)boronic acid

(3-(Ethylcarbamoyl)-4-fluorophenyl)boronic acid

C9H11BFNO3 (211.0815978)


   

Imidazo[1,2-a]pyrazin-3(7H)-one,2-phenyl-

Imidazo[1,2-a]pyrazin-3(7H)-one,2-phenyl-

C12H9N3O (211.07455839999997)


   

(5-(Dimethylcarbamoyl)-2-fluorophenyl)boronic acid

(5-(Dimethylcarbamoyl)-2-fluorophenyl)boronic acid

C9H11BFNO3 (211.0815978)


   

1-(3-chloropyridin-2-yl)piperidin-4-amine

1-(3-chloropyridin-2-yl)piperidin-4-amine

C10H14ClN3 (211.0876194)


   

N-(2-AMINO-4,5,6,7-TETRAHYDROBENZO[D]THIAZOL-6-YL)ACETAMIDE

N-(2-AMINO-4,5,6,7-TETRAHYDROBENZO[D]THIAZOL-6-YL)ACETAMIDE

C9H13N3OS (211.0779288)


   

9H-xanthen-9-ylmethanamine

9H-xanthen-9-ylmethanamine

C14H13NO (211.0997088)


   

Benzamide,N-(2-methylphenyl)-

Benzamide,N-(2-methylphenyl)-

C14H13NO (211.0997088)


   

1-Propanone,1-phenyl-3-(4-pyridinyl)-

1-Propanone,1-phenyl-3-(4-pyridinyl)-

C14H13NO (211.0997088)


   

2,N-DIPHENYLACETAMIDE

2,N-DIPHENYLACETAMIDE

C14H13NO (211.0997088)


   
   

4-(2-Chlorophenoxy)piperidine

4-(2-Chlorophenoxy)piperidine

C11H14ClNO (211.0763864)


   
   
   
   

4,6-diamino-2-phenylpyrimidine-5-carbonitrile

4,6-diamino-2-phenylpyrimidine-5-carbonitrile

C11H9N5 (211.0857914)


   

Phenyl-3-pyrrolidinyl-Methanone HCl

Phenyl-3-pyrrolidinyl-Methanone HCl

C11H14ClNO (211.0763864)


   

1-(4-PHENYLAMINO-PHENYL)-ETHANONE

1-(4-PHENYLAMINO-PHENYL)-ETHANONE

C14H13NO (211.0997088)


   

1-(tert-Butoxycarbonyl)-1H-pyrrole-2-carboxylic acid

1-(tert-Butoxycarbonyl)-1H-pyrrole-2-carboxylic acid

C10H13NO4 (211.0844538)


   

2-amino-3-(2-hydroxy-3-methoxyphenyl)propanoic acid

2-amino-3-(2-hydroxy-3-methoxyphenyl)propanoic acid

C10H13NO4 (211.0844538)


   

3-Phenyl-5-(1H-pyrazol-3-YL)isoxazole

3-Phenyl-5-(1H-pyrazol-3-YL)isoxazole

C12H9N3O (211.07455839999997)


   

1-Hydroxy-5-methylphenazin-5-ium

1-Hydroxy-5-methylphenazin-5-ium

C13H11N2O+ (211.0871336)


   
   

Lorcaserin metabolite M6

Lorcaserin metabolite M6

C11H14ClNO (211.0763864)


   

Lorcaserin metabolite M2

Lorcaserin metabolite M2

C11H14ClNO (211.0763864)


   

Caerulomycinonitrile

Caerulomycinonitrile

C12H9N3O (211.07455839999997)


A pyridine alkaloid that is 2,2-bipyridine-6-carbonitrile substituted by a methoxy group at position 4. Isolated from the marine-derived actinomycete Actinoalloteichus cyanogriseus, it exhibits antineoplastic activity.

   
   

2-chloro-N-ethyl-N-phenylpropanamide

2-chloro-N-ethyl-N-phenylpropanamide

C11H14ClNO (211.0763864)


   

Tyrosine, 3-hydroxy-O-methyl-

Tyrosine, 3-hydroxy-O-methyl-

C10H13NO4 (211.0844538)


   

3-Hydroxy-N-methyl-L-tyrosine

3-Hydroxy-N-methyl-L-tyrosine

C10H13NO4 (211.0844538)


   

N-(4-fluorobenzyl)-4-hydroxybutanamide

N-(4-fluorobenzyl)-4-hydroxybutanamide

C11H14FNO2 (211.1008516)


   

3-(3,4-Dihydroxyphenyl)-2-(methylamino)propanoic acid

3-(3,4-Dihydroxyphenyl)-2-(methylamino)propanoic acid

C10H13NO4 (211.0844538)


   

8-(dimethylamino)-3,4-dihydro-2H-pyrimido[2,1-b][1,3]thiazin-6-one

8-(dimethylamino)-3,4-dihydro-2H-pyrimido[2,1-b][1,3]thiazin-6-one

C9H13N3OS (211.0779288)


   
   

N-beta-Naphthyl-2-pyrrolidone

N-beta-Naphthyl-2-pyrrolidone

C14H13NO (211.0997088)


   

TMPEA

4-13-00-02919 (Beilstein Handbook Reference)

C11H17NO3 (211.1208372)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens

   

beta-(2-Pyridyl)benzenepropanal

beta-(2-Pyridyl)benzenepropanal

C14H13NO (211.0997088)


   

L-4-Hydroxy-3-methoxyphenylalanine

L-4-Hydroxy-3-methoxyphenylalanine

C10H13NO4 (211.0844538)


   

(2S)-2-ammonio-3-(3,4-dihydroxy-5-methylphenyl)propanoate

(2S)-2-ammonio-3-(3,4-dihydroxy-5-methylphenyl)propanoate

C10H13NO4 (211.0844538)


   

2,6-Dihydroxypseudooxynicotinium(1+)

2,6-Dihydroxypseudooxynicotinium(1+)

C10H15N2O3+ (211.108262)


   

[Amino(phenyl)methylidene]-benzylazanium

[Amino(phenyl)methylidene]-benzylazanium

C14H15N2+ (211.123517)


   

3-hydroxy-L-homotyrosine

3-hydroxy-L-homotyrosine

C10H13NO4 (211.0844538)


   
   
   

L-prolyl-L-proline dipeptide

L-prolyl-L-proline dipeptide

C10H15N2O3- (211.108262)


   

(2S,3S)-2-amino-3-hydroxy-4-(4-hydroxyphenyl)butanoic acid

(2S,3S)-2-amino-3-hydroxy-4-(4-hydroxyphenyl)butanoic acid

C10H13NO4 (211.0844538)


   

(2S,3R,4R)-1-(4-aminophenyl)pentane-2,3,4-triol

(2S,3R,4R)-1-(4-aminophenyl)pentane-2,3,4-triol

C11H17NO3 (211.1208372)


   

(Z)-2-(3,4-dimethoxyphenyl)-3-fluoroprop-2-en-1-amine

(Z)-2-(3,4-dimethoxyphenyl)-3-fluoroprop-2-en-1-amine

C11H14FNO2 (211.1008516)


   

4-(2-Naphthyloxy)-2-butyne-1-amine

4-(2-Naphthyloxy)-2-butyne-1-amine

C14H13NO (211.0997088)


   

(2S,3S,4S)-3-(carboxylatomethyl)-4-(prop-1-en-2-yl)pyrrolidine-2-carboxylate

(2S,3S,4S)-3-(carboxylatomethyl)-4-(prop-1-en-2-yl)pyrrolidine-2-carboxylate

C10H13NO4-2 (211.0844538)


   
   

N-methyl-L-dopa zwitterion

N-methyl-L-dopa zwitterion

C10H13NO4 (211.0844538)


   

N-methyl-D-dopa zwitterion

N-methyl-D-dopa zwitterion

C10H13NO4 (211.0844538)


   

3-hydroxy-N-methyl-D-tyrosine

3-hydroxy-N-methyl-D-tyrosine

C10H13NO4 (211.0844538)


   

4-O-methyl-L-dopa zwitterion

4-O-methyl-L-dopa zwitterion

C10H13NO4 (211.0844538)


An aromatic L-alpha-amino acid zwitterion resulting from transfer of a proton from the carboxy to the amino group of 4-O-methyl-L-dopa. Major species at pH 7.3

   

3,6-Diaminoacridine(2+)

3,6-Diaminoacridine(2+)

C13H13N3+2 (211.1109418)


   

Pyridine, 2-(2-(4-methoxyphenyl)ethenyl)-, trans-

Pyridine, 2-(2-(4-methoxyphenyl)ethenyl)-, trans-

C14H13NO (211.0997088)


   

5-Amino-2-methoxyphenol, TMS derivative

5-Amino-2-methoxyphenol, TMS derivative

C10H17NO2Si (211.10285020000003)


   

1-Methyl-4-phenylpyrrolidine-3,3-dicarbonitrile

1-Methyl-4-phenylpyrrolidine-3,3-dicarbonitrile

C13H13N3 (211.1109418)


   

Zalcitabine

Zalcitabine

C9H13N3O3 (211.0956868)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D009676 - Noxae > D000963 - Antimetabolites > D015224 - Dideoxynucleosides D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors Zalcitabine is a potent nucleoside analogue reverse transcriptase inhibitor used in the treatment of HIV infection.

   

isoproterenol

DL-Isoproterenol

C11H17NO3 (211.1208372)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CB - Non-selective beta-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AB - Non-selective beta-adrenoreceptor agonists C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents

   

orciprenaline

metaproterenol

C11H17NO3 (211.1208372)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CB - Non-selective beta-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AB - Non-selective beta-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents

   

3-Amino-1,4-dimethyl-5H-pyrido(4,3-b)indole

3-Amino-1,4-dimethyl-5H-pyrido(4,3-b)indole

C13H13N3 (211.1109418)


D009676 - Noxae > D009153 - Mutagens

   

5-hydroxy-3-methyl-L-tyrosine

5-hydroxy-3-methyl-L-tyrosine

C10H13NO4 (211.0844538)


A tyrosine derivative that is L-tyrosine in which the hydrogens at positions 3 and 5 on the phenyl ring are replaced by a methyl and hydroxy groups respectively.

   

3-O-Methyldopa

3-O-Methyldopa

C10H13NO4 (211.0844538)


A L-tyrosine derivative that is the 3-methoxy derivative of L-dopa.

   

L-Methyldopa

3-Hydroxy-alpha-methyl-DL-tyrosine

C10H13NO4 (211.0844538)


C - Cardiovascular system > C02 - Antihypertensives > C02A - Antiadrenergic agents, centrally acting > C02AB - Methyldopa D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

   

2-methoxy-3-methyl-9H-carbazole

2-methoxy-3-methyl-9H-carbazole

C14H13NO (211.0997088)


   

4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one

4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one

C9H13N3O3 (211.0956868)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D009676 - Noxae > D000963 - Antimetabolites > D015224 - Dideoxynucleosides D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors

   

N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine

N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine

C10H17N3S (211.1143122)


   

N-Acetyl-3-methylhistidine

N-Acetyl-3-methylhistidine

C9H13N3O3 (211.0956868)


   

N-Acetyl-1-methyl-L-histidine

N-Acetyl-1-methyl-L-histidine

C9H13N3O3 (211.0956868)


An N-acetyl-L-amino acid that is N-acetyl-L-histidine in which the hydrogen attached to position 1 on the imidazole ring has been replaced by a methyl group.

   

4-O-methyl-L-dopa

4-O-methyl-L-dopa

C10H13NO4 (211.0844538)


An L-dopa in which the hydroxy group at position 4 is replaced by a methoxy group.

   

5-hydroxy-3-methyl-L-tyrosine zwitterion

5-hydroxy-3-methyl-L-tyrosine zwitterion

C10H13NO4 (211.0844538)


An amino acid zwitterion resulting from a transfer of a proton from the carboxy to the amino group of 5-hydroxy-3-methyl-L-tyrosine; major species at pH 7.3.

   

alpha-Methyl-L-dopa

alpha-Methyl-L-dopa

C10H13NO4 (211.0844538)


A derivative of L-tyrosine having a methyl group at the alpha-position and an additional hydroxy group at the 3-position on the phenyl ring.

   

N-Acetyl-3-methyl-L-histidine

N-Acetyl-3-methyl-L-histidine

C9H13N3O3 (211.0956868)


An N-acetyl-L-amino acid that is N-acetyl-L-histidine carrying a methyl substituent at position 3 on the imidazole ring.

   

pyocyanine(1+)

pyocyanine(1+)

C13H11N2O (211.0871336)


An organic cation resulting from the protonation of pyocyanin.

   

3-O-methyldopa zwitterion

3-O-methyldopa zwitterion

C10H13NO4 (211.0844538)


An aromatic L-alpha-amino acid zwitterion resulting from transfer of a proton from the carboxy to the amino group of 3-O-methyldopa. Major species at pH 7.3

   
   

N-Isopropyl-2-chloroacetanilide

N-Isopropyl-2-chloroacetanilide

C11H14ClNO (211.0763864)


   
   

Hydroxyiminodibenzyl

Hydroxyiminodibenzyl

C14H13NO (211.0997088)


   

methyl (4as,6s,7r,7as)-6-hydroxy-7-methyl-1h,2h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyridine-4-carboxylate

methyl (4as,6s,7r,7as)-6-hydroxy-7-methyl-1h,2h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyridine-4-carboxylate

C11H17NO3 (211.1208372)


   

(5-formyl-1h-pyrrol-2-yl)methyl 4-hydroxybutanoate

(5-formyl-1h-pyrrol-2-yl)methyl 4-hydroxybutanoate

C10H13NO4 (211.0844538)


   

methyl 6-hydroxy-7-methyl-1h,2h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyridine-4-carboxylate

methyl 6-hydroxy-7-methyl-1h,2h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyridine-4-carboxylate

C11H17NO3 (211.1208372)


   

1-carbamoyl-beta-carboline

NA

C12H9N3O (211.07455839999997)


{"Ingredient_id": "HBIN002433","Ingredient_name": "1-carbamoyl-beta-carboline","Alias": "NA","Ingredient_formula": "C12H9N3O","Ingredient_Smile": "NA","Ingredient_weight": "211.22","OB_score": "NA","CAS_id": "38940-60-2","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9233","PubChem_id": "NA","DrugBank_id": "NA"}

   

n-[2,5-dihydroxy-4-(methoxymethyl)phenyl]ethanimidic acid

n-[2,5-dihydroxy-4-(methoxymethyl)phenyl]ethanimidic acid

C10H13NO4 (211.0844538)


   

5,7-dihydroxy-2-(2-hydroxy-2-methylpropyl)azepin-4-one

5,7-dihydroxy-2-(2-hydroxy-2-methylpropyl)azepin-4-one

C10H13NO4 (211.0844538)


   

4-(3-methylbuta-1,3-dien-1-yl)-1h-indole-3-carbaldehyde

4-(3-methylbuta-1,3-dien-1-yl)-1h-indole-3-carbaldehyde

C14H13NO (211.0997088)


   

1,2-dimethyl-9h-carbazol-3-ol

1,2-dimethyl-9h-carbazol-3-ol

C14H13NO (211.0997088)


   

methyl 2-[2-formyl-5-(hydroxymethyl)pyrrol-1-yl]propanoate

methyl 2-[2-formyl-5-(hydroxymethyl)pyrrol-1-yl]propanoate

C10H13NO4 (211.0844538)


   

[2-(ethoxymethyl)-5-formylpyrrol-1-yl]acetic acid

[2-(ethoxymethyl)-5-formylpyrrol-1-yl]acetic acid

C10H13NO4 (211.0844538)


   

n-[2-imino-4-methoxy-6-(methylamino)-1h-pyrimidin-5-yl]-n-methylformamide

n-[2-imino-4-methoxy-6-(methylamino)-1h-pyrimidin-5-yl]-n-methylformamide

C8H13N5O2 (211.10691980000001)


   
   

4-[2-formyl-5-(hydroxymethyl)pyrrol-1-yl]butanoic acid

4-[2-formyl-5-(hydroxymethyl)pyrrol-1-yl]butanoic acid

C10H13NO4 (211.0844538)


   

methyl 5-[(1s,2s)-1,2-dihydroxypropyl]pyridine-2-carboxylate

methyl 5-[(1s,2s)-1,2-dihydroxypropyl]pyridine-2-carboxylate

C10H13NO4 (211.0844538)


   

n-(1,3-dihydroxypropan-2-yl)-2-hydroxybenzenecarboximidic acid

n-(1,3-dihydroxypropan-2-yl)-2-hydroxybenzenecarboximidic acid

C10H13NO4 (211.0844538)


   

3-methoxy-6-methyl-9h-carbazole

3-methoxy-6-methyl-9h-carbazole

C14H13NO (211.0997088)